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Abstract
FUNCTIONAL CHARACTERIZATION OF ATXA,
THE BACILLUS ANTHRACIS VIRULENCE REGULATOR

Publication No.________
Troy G. Hammerstrom, B.S.
Supervisory Professor: Theresa M. Koehler, Ph.D.
Coordinated expression of virulence genes in Bacillus anthracis occurs via a multifaceted signal transduction pathway that is dependent upon the AtxA protein.

Intricate

control of atxA gene transcription and AtxA protein function have become apparent from
studies of AtxA-induced synthesis of the anthrax toxin proteins and the poly-D-glutamic acid
capsule, two factors with important roles in B. anthracis pathogenesis. The amino-terminal
region of the AtxA protein contains winged-helix (WH) and helix-turn-helix (HTH) motifs,
structural features associated with DNA-binding. Using filter binding assays, I determined
that AtxA interacted non-specifically at a low nanomolar affinity with a target promoter (Plef)
and

AtxA-independent

promoters.

AtxA

also

contains

motifs

associated

with

phosphoenolpyruvate: sugar phosphotransferase system (PTS) regulation. These PTSregulated domains, PRD1 and PRD2, are within the central amino acid sequence. Specific
histidines in the PRDs serve as sites of phosphorylation (H199 and H379). Phosphorylation
of H199 increases AtxA activity; whereas, H379 phosphorylation decreases AtxA function.
For my dissertation, I hypothesized that AtxA binds target promoters to activate transcription
and that DNA-binding activity is regulated via structural changes within the PRDs and a
carboxy-terminal EIIB-like motif that are induced by phosphorylation and ligand binding. I
determined that AtxA has one large protease-inaccessible domain containing the PRDs and
the carboxy-terminal end of the protein. These results suggest that AtxA has a domain that is
distinct from the putative DNA-binding region of the protein.
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My data indicate that AtxA activity is associated with AtxA multimerization. Oligomeric
AtxA was detected when co-affinity purification, non-denaturing gel electrophoresis, and
bis(maleimido)hexane (BMH) cross-linking techniques were employed.

I exploited the

specificity of BMH for cysteine residues to show that AtxA was cross-linked at C402,
implicating the carboxy-terminal EIIB-like region in protein-protein interactions. In addition,
higher amounts of the cross-linked dimeric form of AtxA were observed when cells were
cultured in conditions that promote toxin gene expression. Based on the results, I propose
that AtxA multimerization requires the EIIB-like motif and multimerization of AtxA positively
impacts function.
I investigated the role of the PTS in the function of AtxA and the impact of
phosphomimetic residues on AtxA multimerization. B. anthracis Enzyme I (EI) and HPr did
not facilitate phosphorylation of AtxA in vitro. Moreover, markerless deletion of ptsHI in B.
anthracis did not perturb AtxA function. Taken together, these results suggest that proteins
other than the PTS phosphorylate AtxA. Point mutations mimicking phosphohistidine (HD)
and non-phosphorylated histidine (HA) were tested for an impact on AtxA activity and
multimerization.

AtxA H199D, AtxA H199A, and AtxA H379A displayed multimerization

phenotypes similar to that of the native protein, whereas AtxA H379D was not susceptible to
BMH cross-linking or co-affinity purification with AtxA-His.

These data suggest that

phosphorylation of H379 may decrease AtxA activity by preventing AtxA multimerization.
Overall, my data support the following model of AtxA function. AtxA binds to target
gene promoters in an oligomeric state. AtxA activity is increased in response to the hostrelated signal bicarbonate/CO2 because this signal enhances AtxA multimerization.

In

contrast, AtxA activity is decreased by phosphorylation at H379 because multimerization is
inhibited. Future studies will address the interplay between bicarbonate/CO2 signaling and
phosphorylation on AtxA function.
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Chapter I: Introduction
Introduction
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1.1 Gene regulation in response to environmental signals
The ability to respond to niche-specific stimuli is key to thriving in changing
environments and a defining characteristic of life. Organisms within all domains of life have
various methods to react to niche-specific signals, and a common response is to control
gene expression. Cis- and trans-acting factors can promote or impede transcription of genes
encoding proteins that produce a proper response.

In bacteria, the process of signal

transduction occurs most often via classical two-component systems (TCS) containing a
histidine kinase and a response regulator (reviewed in (1). Histidine kinases contain motifs
which sense a change in the environment and then transmit the signal to the kinase domain
to

induce

autophosphorylation.

The

phosphorylated

kinase

domain

promotes

phosphorylation of the response regulator which then interacts with promoter elements of
specific genes.

There are several variations on the theme of TCS. Some systems have

multiple inputs. Some use more than two proteins to shuttle phosphate from the sensing
protein to the regulator.

Sometimes a single protein senses a signal and alters gene

expression. The numerous mechanisms used to respond to the environment indicate that
understanding the proteins involved in signal transduction is crucial to understanding life.
B. anthracis, the etiological agent of anthrax disease, has two distinct lifestyles that
require drastically different gene expression profiles. As a pathogen in mammalian tissue
and as a saprophyte associated with rhizospheres, signal transduction is crucial for the
bacterium to adapt and thrive in each niche. The work I present in this dissertation focuses
on the protein AtxA, which is the linchpin in the transition from a soil-dwelling bacterium to a
mammalian pathogen.

1.2 Bacillus anthracis and Anthrax Disease
B. anthracis is a non-motile, Gram-positive bacterium and contains a 5.23 Mb
chromosome and two large plasmids, pXO1 (182 kb) and pXO2 (96 kb) (2–4). The plasmids
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harbor genes necessary for virulence. The structural genes for the anthrax toxins, pagA
(Protective Antigen, PA), cya (Edema Factor, EF), and lef (Lethal Factor, LF), are located
noncontiguously on pXO1 (Fig. 1-1, (5–7). The capsule biosynthetic operon (capBCADE) is
located on pXO2 (8).
For many years, it was thought that the plasmids were unique to B. anthracis;
however, several strains within the Bacillus cereus group have been isolated with pXO1- or
pXO2-like plasmids (9, 10). In addition to B. anthracis, the B. cereus group includes Bacillus
thuringiensis, an insect pathogen, and B. cereus, an opportunistic pathogen which can also
cause food poisoning. All three of these species normally reside in the soil.
Replication in soil is an under-studied area of the B. anthracis infection cycle. Saile
and Koehler (11) were the first to show germination of spores in the rhizosphere. Cells were
metabolically active as demonstrated by the transfer of genetic material from one strain of B.
anthracis to another. More recently, two studies provided evidence that B. anthracis may
reside within earthworm intestines and that bacteriophages play a significant role in
genotypic and phenotypic alteration (12, 13).
The first step in the infection process occurs when spores from the environment enter
the host. The spores are engulfed primarily by macrophages, although other cell types have
been implicated in this process as well (14, 15). Spores are transported to regional lymph
nodes where they germinate and produce several different virulence factors. After release,
B. anthracis spreads rapidly until the victim perishes due to bacteremia (16). Upon death of
the host, the bacilli develop into dormant spores and re-enter the local ecosystem. B.
anthracis spores are highly resistant for long periods, greater than 200 years (17), to
environmental insults such as heat, desiccation, and UV light.
The route spores of B. anthracis enter the host dictates the symptoms and outcomes
of the infected mammal or human. Cutaneous anthrax manifests when spores invade the
host through a cut or wound in the skin. A large wound called a black eschar develops at the
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site of infection (18, 19).

Gastro-intestinal anthrax occurs when diseased meat or

contaminated food products are eaten. The disease is marked with fever, bloody diarrhea,
vomiting, and abdominal pain (20). B. anthracis is most lethal when spores are inhaled into
the lungs.

The victim develops flu-like symptoms which lead to a misdiagnosis of the

disease (16, 20).

Infections will result in mortality unless the recommended antibiotics,

ciprofloxacin and doxycyline, are administered early during the infection (20, 21).

It is

notable to mention that anthrax disease has not been found to be transmitted from one
person to another.

1.3 Virulence Determinants of B. anthracis
Of the many proteins needed by B. anthracis to cause anthrax disease, the two major
virulence factors are the anthrax toxin and poly-γ-D glutamic acid (PDGA) capsule. The
anthrax toxin proteins are the most abundant proteins secreted from the cell.

Toxemia

induced via injection of the toxins into an animal or delayed antibiotic treatment of an
infection will result in death of the host (22–24). The importance of the PDGA capsule has
also been demonstrated.

A murine model for anthrax disease succumbs to infection of

capsulated, nontoxinogenic strains with a similar dose of spores and survival time as
capsulated, toxinogenic strains (25).
The anthrax toxin is an atypical A-B type toxin which contains a single binding (B)
moiety, protective antigen (PA, 83 kDa), and two enzymatic (A) proteins, edema factor (EF,
89 kDa) and lethal factor (LF, 90 kDa).

After PA binds to the anthrax toxin receptor on host

cell membranes, a furin-like protease cleaves PA to release a 20-kDa fragment (PA20) (26,
27). The remaining 63-kDa PA polypeptide (PA63) spontaneously forms a seven-member
pre-pore structure on the cell membrane (28). The pre-pore, which is capable of binding up
to three molecules of EF and/or LF (29), is endocytosed and transported to early endosomes
(30). Upon acidification of the vesicle, PA forms a pore (31) and facilitates EF and LF
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translocation into the cytoplasm of the host cell (32).

EF functions as a calmodulin-

dependent adenylate cyclase to increase cAMP levels in the afflicted cell (33). Elevated
levels of cAMP, a potent second messaging molecule, cause changes in neutrophil function
and disruptions in the cellular water balance (34). LF is a Zn-dependent metalloprotease
which targets and cleaves mitogen-activated protein kinase kinases (35, 36). Degradation of
the LF targets results in suppression of proinflammatory cytokines (37) and may induce
apoptosis (38).
As a means of evading immune detection, B. anthracis constructs a PDGA capsule.
The capsule is a polymer of amino acid residues while other bacterial capsules are
polysaccharides.

The PDGA capsule is found only in B. anthracis and a few recently

discovered B. cereus and B. thuringiensis strains (9, 10). The humoral response of the
immune system only detects the capsule weakly. This allows the bacteria to proliferate
without raising much alarm.
Lesser known virulence factors also play roles in B. anthracis pathogenesis.
Phospholipases function to cleave the phospholipid head groups from the non-polar tails
resulting in destabilization of the plasma membrane and lysis of the cell.

Three

phospholipases are present in B. anthracis, and each has specificity for a different class of
phospholipids (39). InhA1, a well-studied metalloprotease, has been shown to cleave host
proteins as well as B. anthracis-derived products (24, 40–43). Alo, a cholesterol-dependent
cytolysin, forms pores in host cell membranes leading to the entrance of Ca2+ into the host
cytoplasm (44). Strains with gene deletions of these factors have slightly less virulence than
a parent strain during the course of infection. Nevertheless, each protein is thought to act in
a critical niche or step in pathogenesis (39, 45).
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Figure 1-1. Model of virulence gene activation in B. anthracis. Transcriptional and posttranslational control of AtxA allows B. anthracis to coordinate expression of the toxin genes
(cya, lef, and pagA) and the poly-D-glutamic acid (PDGA) capsule biosynthetic operon
(capBCADE). The atxA gene (colored blue) is affected positively via temperature and
carbohydrate availability and negatively via growth phase cues and redox conditions.
Metabolic activity and phosphorylation of the AtxA PRDs result in stabilization and changes
in the protein’s activity, respectively. The most important signal in the cascade is
CO2/bicarbonate which affects AtxA protein function. Several factors involved in the signal
transduction remain unknown (indicated by the winding black arrows). The known players in
each pathway are in parentheses. AtxA activates transcription (green arrows) of the toxin
genes, acpA, cap operon, and other genes located on pXO1, pXO2, and the chromosome
(not depicted). AcpA and AcpB (colored red) are AtxA-like regulators of the cap operon.
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1.4 The Anthrax toxin Activator, AtxA
The Anthrax toxin Activator AtxA is required for activation of the virulence genes in B.
anthracis (Fig. 1-1, (46–48). Deletion of atxA, which is located on pXO1, leads to attenuation
of virulence in murine models for anthrax disease presumably due to decreased transcription
of the anthrax toxin genes and the capsule biosynthetic operon (46, 47, 49–54). Transcript
levels of at least 47 genes on the virulence plasmids and the chromosome are changed in a
ΔatxA strain (55–57). AtxA-dependent promoters do not display any consensus sequence.
However, all three toxin genes contain structural similarity (58).
The phenotypes of an atxA-null strain indicate that atxA is important for virulence and
that the function of the protein should be discerned. Based on the sequence of the 475
amino acids within AtxA, it is predicted that AtxA contains five motifs (Fig. 1-2) (59, 60). The
56-kDa, soluble basic protein has two DNA-binding motifs at the amino terminus in the form
of

winged-helix

(WH)

and

helix-turn-helix

(HTH)

motifs

(51,

59,

60).

Two

phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) regulation domains
(PRDs) are encoded after the DNA-binding region. The last 90 amino acids are similar to an
Enzyme IIB (EIIB) motif of the PTS (60).
AtxA function is affected by phosphorylation of the PRDs while a metabolic state
regulator impacts AtxA protein amount. The PRDs within AtxA are phosphorylated at H199
and H379 (59). Using HA and HD mutations in AtxA to mimic the non-phosphorylated
and phosphorylated states, respectively, Tsvetanova et al. suggest that a phosphohistidine at
position 199 increases AtxA activity while H379 phosphorylation decreases protein function.
The activity of AtxA is decreased when AtxA is phosphorylated at both residues. CodY is a
pleiotropic regulator which represses genes during early exponential phase of growth when
metabolic activity is high (61). In a ΔcodY strain, AtxA protein amount is decreased severely.
Transcription and translation rates are unaffected in this mutant; therefore CodY regulates
AtxA indirectly via a post-translational mechanism (62).
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Figure 1-2. Comparison of AtxA and PRD-containing proteins. AtxA contains five
putative motifs: a winged helix-turn-helix (WH), a helix-turn-helix (HTH), two PTS regulation
domains (PRDs), and an Enzyme IIB-like (EIIB-like) motif. PRD-containing proteins are
shown as a comparison to AtxA. Mga contains a conserved Mga domain (CMD-1) and two
HTH motifs upstream of the PRDs and EIIB-like motif. MtlR and LicR are similar to AtxA and
Mga; however, MtlR and LicR encode an Enzyme IIA-like (EIIA-like) motif. Another variation
is seen in LevR. It has the same domains as MtlR and LicR, except there is an NtrC Central
Domain and the PRDs are separated by the EIIA-like and EIIB-like motifs. LicT and GlcT are
antiterminators; they contain RNA-binding motifs and two PRDs. Several other PRDcontaining proteins have been discovered (not depicted). Phosphorylated histidines are
labeled for each protein. Phosphorylation sites that lead to increased function of the protein
are colored green, whereas the red residues indicate sites which decrease the protein’s
activity.
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Environmental signals and trans-acting factors, other than CodY, affect atxA
transcription predominantly at the P1 promoter 99 nucleotides upstream of atxA (49). A
second weaker promoter (P2) is located approximately 750 nucleotides in front of the
translational start site (63).

The environmental signals impacting atxA are temperature,

redox state, and carbohydrate availability (64–66). Increased transcription of atxA occurs at
37° C versus 28° C and in the presence of glucose and not glycerol. In agreement, carbon
catabolite activation (CCA) is present, since mutation of the ccpA, encoding the catabolite
control protein A, leads to a decrease in atxA transcription (66). Cytochrome c is involved in
sensing the redox state of the cell.

An increased amount of atxA is detected when

cytochrome c-deficient B. anthracis mutants are cultured in non-toxin inducing conditions
(65). AbrB, a transition state regulatory protein, binds upstream of the P1 transcriptional start
site of atxA and down-regulates atxA during exponential phase of batch culture growth (67,
68).
Several signals affect virulence of B. anthracis; however, CO2/bicarbonate appears to
be the most critical host-associated factor needed for AtxA-dependent virulence gene
expression (Fig. 1-1).

Virulence genes are transcribed optimally when B. anthracis is

cultured in a buffered medium in the presence of bicarbonate and 5% or greater CO 2 (47, 49,
50, 69–71). Previous work demonstrated that the CO2/bicarbonate-dependent induction of
the toxin genes was abrogated in an atxA-null mutant (47). This pointed to atxA as the
mediator for the CO2/bicarbonate signal, but the small molecule does not affect transcription
rate of atxA or stability of the AtxA protein (25, 47, 54, 72).

1.5 Regulation of PRD-containing proteins and CcpA via the Phosphoenolpyruvate:
carbohydrate phosphotransferase system
The role of the PRDs, CcpA, and CodY in AtxA expression and function indicates that
the

metabolic

state

of

B.

anthracis

affects

virulence

gene

regulation.

The
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phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS) is the major
carbohydrate import and utilization machine within bacteria (Fig. 1-3, (73). CcpA activity and
regulation of PRDs is controlled by the PTS.
The primary task of the PTS is to recycle phosphate from the end of glycolysis to
carbohydrates as they enter the cell. The PTS is composed of two general enzymes,
Enzyme I (EI) and HPr, and sugar-specific Enzyme II (EII) complexes.

PTS-dependent

carbohydrates are recognized and transported via one of four EII superfamilies: the glucosefructose-lactose superfamily, the ascorbate-galactitol superfamily, the mannose family, and
the dihydroxyacetone family.

EII complexes consist of A, B, C, and in some cases D

motifs/proteins and may be one protein with multiple domains (EIIABC) or divided into up to
four proteins containing each motif separately or in tandem (i.e. EIIA and EIICB) (73).
The phosphotransfer begins as EI catalyzes the conversion of phosphoenolpyruvate
(PEP) to pyruvate resulting in EI phosphorylated at a conserved histidine. EI~P transfers the
chemical group to HPr at H15 (Bacillus subtilis numbering), which subsequently
phosphorylates EIIA. EIIA~P phosphorylates EIIB which transfers its phosphate to
carbohydrate molecules crossing the cell membrane via the EIIC(D) complex.

The

phosphorylated sugar serves as a substrate in glycolysis or other catabolic pathways (73).
It is significant to note that the PTS also functions to regulate gene expression based
on available sugars. HPr is the main player in carbon catabolite repression (CCR) and
carbon catabolite activation (CCA) in low-G+C Gram-positive bacteria, such as B. anthracis
(Fig. 1-3). In addition to EI-dependent phosphorylation of HPr at H15 (P~His-HPr), the HPr
kinase/phosphorylase (HprK/P) phosphorylates HPr at S46 (P-Ser-HPr).

EI activity is

affected by the PEP/pyruvate ratio; whereas, HprK/P modifies HPr in an ATP-dependent
manner in response to high levels of fructose-1,6-bisphosphate.

Two methods of HPr-

dependent signaling relevant to this work include activation of the catabolite control protein
(CcpA) and phosphorylation of PTS regulation domains (PRDs) (73).
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Figure 1-3. HPr-dependent processes related to carbohydrate metabolism.
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Figure 1-3. HPr-dependent processes related to carbohydrate metabolism. HPr is
phosphorylated by Enzyme I (EI) or HprK/P. EI converts PEP to pyruvate when PEP
concentrations are high.
The reaction produces a phosphorylated EI.
(1) EI~P
phosphorylates HPr at His15. (2) EIIA is one target of P~His-HPr. P~EIIA phosphorylates
EIIB, which in turn phosphorylates the sugar (S) transported via EIIC/D. (3) PRD-containing
proteins are phosphorylated by P~His-HPr to induce activity whereas EIIA- or EIIBdependent phosphorylation decreases activity.
PRD-containing proteins function as
transcriptional antiterminators or activators. P~His-HPr has other targets not depicted. (4)
Ser46 of HPr is phosphorylated by HprK/P when high levels of ATP and fructose-bis-1,6phosphate (FBP) are present. P-Ser-HPr forms a heterotetramer with CcpA, and (5) the
complex binds to promoters to induce carbon catabolite activation (CCA) or repression
(CCR). Blue arrows represent a transfer of phosphate. Black arrows indicate other
processes.
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CcpA, a B. subtilis DNA binding protein within the LacI/GalR family of transcriptional
regulators, induces CCA and CCR after interacting with P-Ser-HPr or an HPr-like protein
called Crh (reviewed in (74).

Similar to HPr, Crh can be phosphorylated at S46.

Heterotetramers of CcpA/P-Ser-HPr or CcpA/P-Ser-Crh bind to catabolite response elements
(cre) located in promoter regions. If a cre is upstream of a transcriptional start site, CcpA/PSer-HPr will activate the promoter upon binding. Conversely, when the cre is downstream of
the transcriptional start, CcpA/P-Ser-HPr acts as a repressor to decrease transcription of the
gene. The CcpA/P-Ser-HPr regulon includes ~10% of the B. subtilis genome, and in several
pathogenic bacteria, CcpA plays a role in virulence (75). Deletion of ccpA in B. anthracis
causes a decrease in the transcription of atxA (66). Transcription of mga, the regulator of
early virulence traits in group A Streptococcus (GAS), is affected by ccpA (76).
PRD-containing

proteins

typically

function

as

transcriptional

activators

or

antiterminators. The B. subtilis protein LicT is the prototypical PRD-containing protein. It
contains an amino-terminal RNA-binding motif followed by two PRDs (Fig. 1-2).

LicT

antiterminates transcription of genes needed to import and metabolize β-glucosides (77).
The effect of the PTS on PRD-containing proteins is varied for each regulator and can be
different based on the sites phosphorylated via P~His-HPr and a specific class of EIIA and/or
EIIB (Fig. 1-3). In LicT, HPr phosphorylates H207 and H269 within PRD2 and H100 in PRD1
is phosphorylated by BglP, the β-glucosides-specific EIIBCA complex (78). Structural studies
have shown that the HPr-dependent phosphorylation of PRD2 promotes dimer formation
causing an increase LicT activity (79).

In contrast, phosphorylation of PRD1 decreases

activity by destabilizing the dimeric form (80). Based on the study of LicT and other PRDcontaining antiterminators, PRDs have three main properties: (i) PRDs contain 5 α-helices,
(ii) histidine residues within the PRDs are phosphorylated via proteins in the PTS, and (iii)
phosphorylation of the PRDs leads to structural changes affecting the activation state of the
protein.
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Other PRD-containing proteins function as transcriptional activators. LicR and MtlR
contain DNA-binding motifs at the amino-terminus, followed by two PRDs, an EIIB-like motif
and an EIIA-like motif (Fig 1-2, ((81, 82)). Slight variations on the motif organization also exist
since LevR contains an NtrC central domain and has its PRDs separated by EIIA-like and
EIIB-like motifs (83).

Like LicT, the PRDs within these proteins are phosphorylated;

however, EIIB-like and EIIA-like motifs can be phosphorylated as well (73). Modification of
MtlR,

a

regulator

of

mannitol

utilization

found

in

B.

subtilis

and

Geobacillus

stearothermophilus, is the best understood of the PRD-containing transcriptional activators
(82, 84, 85). PRD2 of MtlR contains two histidines that are phosphorylated by HPr. The Mtlspecific EIIA (EIIAMtl) phosphorylates MtlR at a conserved cysteine in the EIIB-like motif, and
the EIIBMtl domain (within the EIICBMtl protein) is responsible for phosphorylating H599 in the
EIIA-like motif of MtlR (82). Phosphorylation of PRD2 induces DNA binding by MtlR while
phosphorylation of the EIIB-like or EIIA-like motif is antagonistic (84).

1.6 AtxA homologues in Gram positive low G+C pathogens
Recently, PRDs were discovered in several virulence gene regulators: Mga in GAS;
AtxA, AcpA, and AcpB in B. anthracis; and the Mga-like protein and EbpR in Enterococcus
faecalis (59, 86–88). These proteins contain amino-terminal DNA-binding motifs, internal
PRDs, and a carboxy-terminal EIIB-like motif and regulate virulence-associated genes (Fig.
1-2, (86). This small family of proteins could have functional and structural similarity.
The most-studied of the PRD-containing virulence regulators is Mga (86). Originally
described as the regulator of the emm gene, Mga controls approximately 10% of the GAS
genome during exponential phase of growth (89).

In vitro electrophoretic mobility shift

assays (EMSAs) show Mga binding specifically to several GAS promoters (90). Mga has
three amino-terminal features that affect DNA binding and gene activation. One major HTH
(HTH-4, residues 107-126) and one minor HTH (HTH-3, residues 53-72) are thought to
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interact with DNA specifically (91). In addition, a small motif called the conserved Mga
domain-1 (CMD-1) is required for Mga-dependent activation of promoters (92). Recently,
Mga has been shown to contain an EIIB-like motif and to be phosphorylated via HPr and EI
(McIver, personal communication).

Phosphorylation of H204 and H270 decreases Mga

activity, whereas phosphorylation of H324 increases the function of the protein.
The Anthrax capsule Activator (AcpA) and AcpB, a homologue of AcpA, are encoded
on pXO2 of B. anthracis and are part of the AtxA/Mga family.

The proteins have high

similarity to each other (62%) and to AtxA (AcpA-AtxA, 50%; AcpB-AtxA, 50%; Drysdale,
2004). The capsule biosynthesis operon is regulated at the transcriptional level via AtxA,
AcpA, and AcpB (Fig. 1-1, (93, 94)). In a laboratory-derived, genetically-complete strain of B.
anthracis, atxA and either acpA or acpB are necessary for PDGA capsule synthesis. Single
deletions of acpA or acpB resulted in an insignificant decrease in capsule production. AcpA
and AcpB may appear to be functionally redundant; however, a ΔacpB strain is slightly
attenuated compared to the parent and ΔacpA strains (25). AtxA increases expression of
acpA twenty-fold at one of its two promoters, and the other promoter is activated at a low
constitutive level. In addition to an atxA-independent promoter directly upstream of acpB, its
transcript level is thought to be enhanced by read-through transcription from the cap operon
(95).
The only structural information about an AtxA/Mga family member was obtained when
researchers at the Argonne National Laboratory solved the X-ray crystal structure of an Mgalike protein from E. faecalis (PDB entry 3SQN,(88)).

No functional or genetic data is

available for this protein, except that it crystallized as a dimer. The structure shows the EIIBlike motif from one monomer is encircled by the DNA-binding motif and PRDs of the other
monomer (Fig 1-4).

Interestingly, another AtxA/Mga-like protein, EbpR, is present in E.

faecalis and regulates pilus biogenesis and biofilm formation (87). Similar to AtxA, EbpR
function is increased in buffered medium containing bicarbonate and CO2 (96).
15

Figure 1-4. Crystal structure of the Mga-like protein of E. faecalis. The cartoon
structure of the Mga-like protein homodimer (3sqn PDB file) is shown. Subunit A is colored
blue. The DNA-binding elements and PRDs of Subunit B are red and the EIIB-like motif is
green. Three representations of the structure are shown with different rotations around the
y- or x-axis.
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1.7 Gaps in knowledge and significance of this work
Studies of AtxA protein function in B. anthracis will reveal the mechanism used to
control virulence gene expression in response to environmental signaling. Moreover, the
knowledge of the specific system used by B. anthracis will increase our overall
understanding of signal transduction and microbial pathogenesis.
B. anthracis is a model bacterial pathogen. Few bacteria require both intracellular
and extracellular mechanisms of immune evasion and survival. The organism utilizes toxins
and a capsule like other pathogens, yet the virulence traits within B. anthracis have several
unique features. The genome contains a chromosome and two large virulence plasmids
which encode for the virulence factors.

Regulators on all three genetic elements can

influence gene expression on the other DNA molecules. The processes of spore formation
and germination allow for studies related to the development and morphogenesis of
organisms. Finally, powerful biochemical and genetic tools, many developed in the related
species B. subtilis, are available when working with B. anthracis.
Activation of B. anthracis virulence requires AtxA; however, it is not understood how
AtxA functions to regulate virulence genes. For my thesis work, I hypothesize that AtxA
binds target promoters to activate transcription when structural changes within the PRDs and
EIIB-like motif are induced by phosphorylation and/or ligand binding. WH and HTH motifs
indicate DNA-binding activity though specific binding of DNA has not been shown (51, 60).
Tsvetanova et al. (59) demonstrated that AtxA is phosphorylated and suggested the PTS is
involved in phosphorylation. The effect of phosphorylation and the proteins responsible have
not been identified. AtxA function is strongly induced in the presence of CO 2/bicarbonate, but
the molecular mechanism for the impact of this signal on protein function has not been
discerned.
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Chapter II: Materials and Methods
Materials and Methods

NOTE: A portion of this chapter is derived from work that has been published in 2011: “The
Bacillus anthracis virulence regulator AtxA: oligomeric state, function, and CO2-signaling.”
Molecular Microbiology 82(3): 634-47 PMID:21923765. I am the primary author on this
paper. I performed all experiments described in this chapter. I have received permission by
the publisher of Molecular Microbiology, John Wiley and Sons, to reproduce all of the
manuscript in print or electronically for the purposes of my dissertation (License Number:
2796030226674)
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2.1 Culture conditions
“B. anthracis strains were cultured at 37° C in Luria-Bertani (LB) medium (97),
Brain Heart Infusion (BHI) medium(98) or Casamino Acid (CA) medium (99). LB broth
cultures were shaken in air.

CA broth cultures were shaken in air or in 5%

atmospheric CO2. For CA cultures incubated in elevated CO2, 0.8% sodium
bicarbonate was added to the medium (CACO3) (100). Cells from stationary phase
cultures were transferred into fresh medium (CACO3, unless noted otherwise) to an
initial optical density at 600nm (OD600) of approximately 0.08.

Cultures were

incubated for 7 h and the OD600 was determined hourly. Generally, cultures reached
early-exponential phase (OD600 0.20 to 0.35) at 2 h and stationary phase (OD600 1.2
to 1.7) at 4 h. For strains harboring atxA controlled by the hyper-spank promoter
(Phs) (101), expression was induced with 30-50 µM isopropyl β-D-thiogalactoside
(IPTG) at 2 h and cells were harvested at 4 h.
“Antibiotics were used when appropriate in the following concentrations:
spectinomycin (50 µg ml-1 for E. coli and 100 µg ml-1 for B. anthracis), erythromycin
(150 µg ml-1 for E. coli and 5 µg ml-1 for B. anthracis), and carbenicillin (100 µg ml-1 for
E. coli). Antibiotics and other chemicals were purchased from Fisher Scientific
(Fairlawn, NJ) or Sigma-Aldrich (St. Louis, MO) unless indicated otherwise.” (102)

2.2 Strain Construction
“B. anthracis strains and plasmids are shown in Table 2-1. All B. anthracis
mutants were derived from the parent strain ANR-1 (Ames non-reverting), a pXO1+
pXO2- isolate originally obtained from Ames (pXO1+ pXO2+) (103). E. coli strains
JM109, TG1, and GM2163 were employed as hosts for cloning plasmids.
Amplification, manipulation, and isolation of plasmid DNA were performed according
to general practices. Non-methylated plasmid DNA was obtained from E. coli
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Table 2.1 B. anthracis strains and plasmids
Name
Strains
ANR-1
UT375
UT376

Description

UT405
UT408

ANR-1, ptsHI-null
This work
lef promoter–lacZ fusion (Plef-lacZ) at native lef locus, This work
ptsHI-null

Plasmids
pHT304-18z
pUTE657

Reference

Parent strain, pXO1+, pXO2(103)
lef promoter–lacZ fusion (Plef-lacZ) at native lef locus This work
lef promoter–lacZ fusion (Plef-lacZ) at native lef locus, This work
atxA-null

Low-copy vector harboring a promoter-less lacZ; Erm
Expression vector derived from pDR111 and pBC16
R
R
with IPTG-inducible Phyper-spank; Spec Amp
pUTE658
pUTE657 - derived expression vector for AtxA; the
atxA ribosome binding site and coding region
controlled by Phyper-spank
pHT304-18z - derived reporter vector for atxA; -72 to
pUTE843
+99 of the atxA promoter (relative to the P1
transcriptional start) is upstream of lacZ
pUTE991
pUTE658 - derived expression vector for AtxA-His
(hexa-histidine tag on the C-terminus of AtxA)
pUTE992
pUTE658 - derived expression vector for AtxA-FLAG
(FLAG tag on the C-terminus of AtxA)
pUTE1013
pUTE657 - derived expression vector for GFP-FLAG
(FLAG tag on the C-terminus of GFP); the gfpmut3a
ribosome binding site, coding region, and sequence
encoding FLAG controlled by Phyper-spank
pUTE1018-FLAG pUTE657 - derived expression vector for AtxA1-164FLAG (FLAG tag on the C-terminus); the atxA
ribosome binding site, coding region, and sequence
encoding FLAG controlled by Phyper-spank
pUTE1019-FLAG pUTE657 - derived expression vector for AtxA1-385FLAG (FLAG tag on the C-terminus); the atxA
ribosome binding site, coding region, and sequence
encoding FLAG controlled by Phyper-spank

R

(104)
(105)
This work

(106)

This work
This work
This work

This work

This work

pUTE1020-GFP- pUTE657 - derived expression vector for AtxA167-385- This work
FLAG
GFP-FLAG (GFP-FLAG tag on the C-terminus); the
atxA ribosome binding site, coding region, and
sequence encoding GFP-FLAG controlled by Phyperspank
pUTE1021-GFP- pUTE657 - derived expression vector for AtxA167-475- This work
FLAG
GFP-FLAG (GFP-FLAG tag on the C-terminus); the
atxA ribosome binding site, coding region, and
sequence encoding GFP-FLAG controlled by Phyperspank
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Table 2.1 B. anthracis strains and plasmids (continued)
Name
pUTE1022FLAG

pUTE1022GFP-FLAG

pUTE1032

pUTE1034

pUTE1040

Description
pUTE657 - derived expression vector for AtxA385-475FLAG (FLAG tag on the C-terminus); the atxA
ribosome binding site, coding region, and sequence
encoding FLAG controlled by Phyper-spank
pUTE657 - derived expression vector for AtxA385-475GFP-FLAG (GFP-FLAG tag on the C-terminus); the
atxA ribosome binding site, coding region, and
sequence encoding FLAG controlled by Phyperspank
pUTE657 - derived expression vector for His-HPr
(hexa-histidine tag on the N-terminus of HPr); the
ptsH ribosome binding site, sequence encoding the
His tag, and ptsH coding region controlled by
Phyper-spank
pUTE657 - derived expression vector for HPr and
EI; the ptsH ribosome binding site, ptsH coding
region, ptsI ribosome binding site, and ptsI coding
region controlled by Phyper-spank
pUTE657 - derived expression vector for His-EI
(hexa-histidine tag on the N-terminus of EI); the ptsI
ribosome binding site, sequence encoding the His
tag, and ptsI coding region controlled by Phyperspank

Reference
This work

This work

This work

This work

This work
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GM2163 for electroporation into B. anthracis (47, 107).
“All gene deletions were inserted using derivatives of pHY304, a temperaturesensitive E. coli – B. anthracis shuttle vector harboring an erythromycin-resistance
gene (108).

To construct UT375, in which the lef coding sequence on pXO1 was

replaced by a promoterless -galactosidase gene (lacZ), the polymerase chain
reaction (PCR) and primers TH126 and TH127 (Table 2-2) were used to amplify a
797-bp DNA fragment corresponding to sequence from -686 to +111 relative to the lef
transcriptional start site (lefup) (49). The PCR product was cloned into pHT304-18z
(109) using PstI and BamHI restriction enzyme sites upstream of the plasmid-borne
lacZ. Subsequently, a 854-bp DNA sequence corresponding to sequences +2510 to
+3363 (lefdown) was amplified using primers TH128 and TH129 and cloned into the
KpnI and EcoRI sites of pHT304-18z containing lefup. The lefup-lacZ-lefdown segment of
DNA was removed via digestion with XhoI and EcoRI and cloned in pHY304.
Integration of the plasmid was performed according to methods described previously
(105).

Briefly, B. anthracis containing the plasmid was cultured at 41° C (the

temperature non-permissive for pHY304 replication) in the presence of erythromycin
to select for isolates in which the plasmid inserted into the lef locus via homologous
recombination. Subsequently, cultures were passaged multiple times at 30° C in the
absence of antibiotic to allow excision of the pHY304 derivative from the lef locus.
Single colony isolates were tested using PCR and sequencing for replacement of the
lef coding sequence with the promoterless -galactosidase gene.
“To generate UT376, a markerless atxA-deletion mutant of UT375, DNA
fragments corresponding to approximately 1 kb upstream of the atxA translational
start (-1009 to +99 from the P1 transcriptional start site) and 1 kb downstream of the
atxA stop codon (+1528 to +2517) were amplified using primers JR170-171 and
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Table 2.2 Primers used in this dissertation
Name
TH126
TH127
TH128
TH129
JR170
JR171
JR172

Brief Description
Plef-lacZ insertion
Plef-lacZ insertion
Plef-lacZ insertion
Plef-lacZ insertion
atxA markerless deletion
atxA markerless deletion
atxA markerless deletion

Sequence (5' to 3')
GACTCTGCAGCTCGAGTATGCAGTGAGGCTCTTATGATT
GATAGGATCCATAAAGACGGGACCACTCAAAG
CAGTGGTACCGGGACCAGCCATTATGAAGCAAC
GGAAGAATTCAAGATGAAGATCGACAAAATGGCTC
GGCCGCGGAGAGCCGCATTAAACT
GGGCATGTCTATAATTGATTCTCCTTTCCTG
GAGAATCAATTATAGACATGCCCTTTAAATATTTGTTTA
ATGACAC

JR173
TH235
TH244
TH245

atxA markerless deletion
ptsHI markerless deletion
ptsHI markerless deletion
ptsHI markerless deletion

GGCTCGAGCGCTTGTCTCACAATCTCATC
GAGATCTAGACTAGTAGCACTTGGTGGTAAAG
CAGCCTCGAGTTCATACGGAAGCTTTATCGCAC
CGACTCAGGTTTTTTTATTAATTACATGATAATTTATCT
CC

TH246

ptsHI markerless deletion

GGAGATAAATTATCATGTAATTAATAAAAAAACCTGAGT
CG

TH191
TH192
TH198

atxA
atxA
atxA
stop

rbs (SalI)
stop codon (SphI)
codon 475 + FLAG +
(SphI)

GGTAGTCGACAGGAAAGGAGAATCAATTATAGACATGC
CCTTGCATGCTTATATTATCTTTTTGATTTCATG
GGGCATGCTATTTATCATCATCATCTTTATAATCTATTA
TCTTTTTGATTTCATGAAAAT

TH199

atxA codon 475 + His6 +
stop (SphI)

GGGCATGCTAGTGGTGGTGGTGGTGGTGTATTATCTTTT
TGATTTCATGAAAAT

TH254

atxA rbs + codon 167
(SalI)

CCAAGTCGACAGGAAAGGAGAATCAATTATAGACATGTA
TTGGCCGTTTCCCTATATTAA

TH247

atxA rbs + codon 385
(SalI)

CCAAGTCGACAGGAAAGGAGAATCAATTATAGACATGCT
ATTTAAAAATAACCCG

TH257

atxA codon 164 + FLAG +
stop codon (SphI)

GGGCATGCTATTTATCATCATCATCTTTATAATCTGGAA
TATTGCAATATAACC

TH260

atxA codon 385 + FLAG +
stop codon (SphI)

GGGCATGCTATTTATCATCATCATCTTTATAATCCATAC
GTTGAGTTTCAAAATGCATTG

TH267

atxA codon 385 + gfp-mut3a
start (Forward)

CAATGCATTTTGAAACTCAACGTATGATGAGTAAAGGAG
AAGAACTTTTCAC

TH268

atxA codon 385 + gfp-mut3a
start (Reverse)

GTGAAAAGTTCTTCTCCTTTACTCATCATACGTTGAGTT
TCAAAATGCATTG

TH212

atxA codon 475 + gfp-mut3a
start (Forward)

GATTTTCATGAAATCAAAAAGATAATAATGAGTAAAGGA
GAAGAACTTTTCAC

TH213

atxA codon 475 + gfp-mut3a
start (Reverse)

GTGAAAAGTTCTTCTCCTTTACTCATTATTATCTTTTTG
ATTTCATGAAAATC

TH228
TH229
TH216
TH217
TH218
TH219

atxA
atxA
atxA
atxA
atxA
atxA

CTAAATCTTCAAATTAGTGAAGAACTTGTATTC
GAATACAAGTTCTTCACTAATTTGAAGATTTAG
ATGTTAAGGTTATATAGTAATATTCCAAATGAT
ATCATTTGGAATATTACTATATAACCTTAACAT
TCAAAACACAAATTGAGTGTGTTGTTCGCTATA
TATAGCGAACAACACACTCAATTTGTGTTTTGA

C96S
C96S
C161S
C161S
C202S
C202S
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Table 2.2 Primers used in this dissertation (continued)
Name
TH230
TH231
TH222
TH223
TH224
TH225
TH183
TH184
TH22
TH23
TH185
TH186
TH24
TH25
TH193
TH234

Brief Description
atxA C356S
atxA C356S
atxA C370S
atxA C370S
atxA C402S
atxA C402S
atxA H199A
atxA H199A
atxA H199D
atxA H199D
atxA H379A
atxA H379A
atxA H379D
atxA H379D
gfp-mut3a rbs (SalI)
gfp-mut3a stop codon +
FLAG (SphI)

Sequence (5' to 3')
AATACAATTCAAGAAAGTATTAGTAATTTAAAC
GTTTAAATTACTAATACTTTCTTGAATTGTATT
TACTCCCATTTCGACAGTTATGAAATTTCATTA
TAATGAAATTTCATAACTGTCGAAATGGGAGTA
TACACCTCACAAGGAAGTATACATCGAGAG
CTCTCGATGTATACTTCCTTGTGAGGTGTA
CAAATGTACACCTATTCAAAAGCCAAATTGTGTGTG
CACACACAATTTGGCTTTTGAATAGGTGTACATTTG
CAAATGTACACCTATTCAAAAGACAAATTGTGTGTG
CACACACAATTTGTCTTTTGAATAGGTGTACATTTG
CATTATTAACAATGGCTTTTGAAACTCAACGTATGC
GCATACGTTGAGTTTCAAAAGCCATTGTTAATAATG
CATTATTAACAATGGATTTTGAAACTCAACGTATGC
GCATACGTTGAGTTTCAAAATCCATTGTTAATAATG
GCGCGTCGACCTCTAGATTTAAGAAGGAGATATAC
GGGCATGCTATTTATCATCATCATCTTTATAATCTTTGT
ATAGTTCATCCATGCCATG

MT10
TH286

ptsH rbs (SalI)
ptsH His6 + 5' end of ORF

GGTAGTCGACATTTAAAGGAGATAAATTATCATG
GCACACCACCACCACCACCACGAAAAAATCTTTAAAGTA
ACTAGCG

TH287

ptsH rbs + His6

GTGGTGGTGGTGGTGGTGTGCCATGATAATTTATCTCCT
TTAAATGTC

TH288
MT12
TH289
TH290

ptsH
ptsI
ptsI
ptsI

ATGCATGCTTATTCTCCTAATCCTTCG
GGTAGTCGACAACGAAGGATTAGGAGAATAATG
GCACACCACCACCACCACCACACTCTTAACATTCAAGGG
GTGGTGGTGGTGGTGGTGTGCCATTATTCTCCTAATCCT
TCGTTGTC

MT13
TH195

ptsI stop codon (SphI)
pUTE657 sequencing primer
(upstream)

GGGCATGCATCGACTCAGGTTTTTTTATTAATTA
GAACGTTGCTCGAGGGTAAATG

TH196

pUTE657 sequencing primer
(downstream)

GGTACGTACGATCTTTCAGCC

stop codon (SphI)
rbs (SalI)
His6 + codon 2
rbs + His6

Abbreviations: rbs, ribosome binding site; His6, hexa-histidine tag; ORF, open reading frame
Restriction enzymes are listed in parentheses. If the primer encodes a point mutation, the
mutagenic codon is underlined.
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JR172-173, respectively (Table 2-2), fused via splicing by overlapping extension PCR
(PCR-SOE) (110), and inserted into pHY304 using the SacII and XhoI restriction
enzyme sites.

B. anthracis containing the Plef-lacZ reporter (UT375) was

transformed with the atxA deletion construct. The strain was cultured as described
above and an isolate deleted for atxA was confirmed using PCR and sequencing.”
(102)
The vector used to remove ptsHI from the B. anthracis chromosome contained
sequences homologous to the regions upstream of ptsH and downstream of ptsI. Primers
TH235 and TH245 facilitated amplification of a 869-nt sequence upstream of the ptsH
(GBAA_4268) start codon while TH246 and TH244 were used to amplify a 873-nt region
downstream of the ptsI (GBAA_4267) stop codon. The products were fused via PCR-SOE
and cloned into pHY304 using the XbaI and XhoI restriction enzyme sites. The plasmid
containing the ptsHI flanking regions was electroporated into ANR-1 and UT375 to produce
the ptsHI-null strains (UT405 and UT408, respectively) using the methods described above
for gene deletion.
“I cloned the atxA coding region into pUTE657 (105), which carries the IPTGinducible promoter Phyper-spank (Phs) from pDR111 (101) and the origin of
replication from pBC16.

The atxA gene was amplified using TH191 and TH192

(Table 2-2) to add a SalI site 5’ of the ribosome binding site (rbs, +76 from P1) and a
SphI site after the translational stop codon.

The resulting plasmid (pUTE658)

contains atxA controlled by Phs.
“I used a comparable strategy to clone the gfp-mut3a sequence (111) into
pUTE657, yielding pUTE1013. Using TH193 and TH234 (Table 2-2), the gfp-mut3a
sequence was PCR amplified from pAD123 (112) to include the ribosome binding site
and to add a C-terminal FLAG tag to gfp-mut3a.” (102)
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I constructed B. anthracis strains carrying Phs –controlled atxA alleles on pUTE657 to
allow expression of carboxy-terminal epitope-tagged parent and mutant AtxA proteins.
Mutant alleles were generated using PCR-SOE and appropriate oligonucleotide primers
(Table 2-2). For carboxy-terminal epitope tags (FLAG and hexa-His), primers were designed
to encode the desired tag at the 3’ end of atxA prior to the stop codon. To create 5’ deletions
of atxA, oligonucleotides fused the rbs of atxA to codon 167 or 385 (TH254 or TH247). For
3’ deletions of atxA, a FLAG-tag and stop codon were inserted after the 164th or 385th codon
(TH257 or TH260). AtxA-GFP-FLAG fusions were created using PCR-SOE to connect the
385th (TH267 and TH268) or 475th codons (TH212 and TH213) of atxA to the gfp-mut3a
sequence containing a carboxy-terminal FLAG tag. Each of the atxA alleles was cloned into
the SalI and SphI sites of pUTE657. In total, I produced six vectors (AtxA truncations):
pUTE1018-FLAG (AtxA1-164-FLAG), pUTE1019-FLAG (AtxA1-385-FLAG), pUTE1020-GFPFLAG (AtxA167-385-GFP-FLAG), pUTE1021-GFP-FLAG (AtxA167-475-GFP-FLAG), pUTE1022FLAG (AtxA385-475-FLAG), and pUTE1022-GFP-FLAG (AtxA385-475-GFP-FLAG) (Table 2-1).
To express proteins within B. anthracis, I inserted genes of interest into the pUTE657
vector. The ptsHI genes were amplified using MT10 and MT13 and subsequently cloned into
the SalI and SphI sites of pUTE657. The resulting vector (pUTE1034, Table 2-1), was used
as a template to generate an amino-terminal hexa-His tagged HPr in pUTE657 (pUTE1032).
Using a primer upstream of Phs on pUTE657 (TH195) and TH286, I added the hexa-His tag
after the rbs and start codon of ptsH. Using PCR-SOE the product was combined with
sequences representing the entire coding region, minus the start codon, of ptsH (TH287 and
TH288). Similarly, the ptsI open reading frame was cloned into pUTE657. Oligonucleotides
MT12 and MT13 amplified the region and contained the enzyme restriction sites to clone the
sequence into pUTE657. The construct served as the template to create an amino-terminal
fusion of the His6 tag and ptsI. The rbs and start codon were added to the hexa-His tag
using TH195 and TH289. The remaining ptsI sequence was amplified using TH290 and
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MT13. The two DNA products were connected using PCR-SOE. The vector encoding the
His-tagged EI is pUTE1040.

2.3 AtxA-His purification
“The recombinant epitope-tagged protein AtxA-His was purified from B.
anthracis using affinity chromatography. B. anthracis UT376 (pUTE658) was cultured
in 2-L baffled flasks containing 750 ml CACO3. Following induction with 50 µM IPTG,
cells were harvested using centrifugation at 6200 x g for 10 min at 4° C. Cells were
resuspended in 3 ml Binding Buffer (5 mM imidazole, 0.5 M NaCl, 5 mM βmercaptoethanol, 20 mM Tris pH 7.2,) supplemented with 1X EDTA-free Complete
proteinase inhibitor (Roche, Indianapolis, IN), 1 mM MgCl2, and 10 units DNAse I
(Ambion, Inc., Austin, TX). Cells were lysed via three passages through a French
Pressure Cell Press (SLM Instruments, Inc., Urbana, IL) and soluble material was
obtained following centrifugation at 30,000 x g for 20 min at 4° C. Lysates were
added to 1 ml NTA-Ni resin (Qiagen, Hilden, Germany) in Binding Buffer (total volume
of 10 ml) and the suspension was mixed gently for 2 h at 4° C. The resin was
washed in batch three times with 4 ml of Binding Buffer and once with 4 ml of Wash
Buffer 1 (40 mM imidazole pH 7.9, 1.0 M NaCl, 20 mM Tris pH 7.2, 5 mM βmercaptoethanol). The resin was transferred to a gravity column and washed
sequentially with (1) 10 ml Wash Buffer 1, (2) 1.5 ml Wash Buffer – High Salt (40 mM
imidazole pH 7.9, 1.5 M NaCl, 20 mM Tris pH 7.2, 5 mM β-mercaptoethanol), (3) 2.5
ml Wash Buffer 1, (4) 1.5 ml Wash Buffer 2 (75 mM imidazole pH 7.9, 1.0 M NaCl, 20
mM Tris pH 7.2, 5mM β-mercaptoethanol), and (5) 2.5 ml Wash Buffer 1. Upon
addition of 7.5 ml Elution Buffer (20 mM Tris pH 7.2, 800 mM imidazole pH 7.9, 500
mM NaCl, 5 mM β-mercaptoethanol), 250 µl fractions were collected in 1.5-ml tubes
containing 250 µl Collection Buffer (20 mM Tris pH 7.2, 150 mM NaCl, 10% glycerol,
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5 mM EDTA, 5 mM β-mercaptoethanol).

Protein concentration and purity of the

fractions were assessed using the Bradford reagent (Bio-Rad, Hercules, CA) and
SDS-PAGE with Coomassie staining (1% coomassie brilliant blue, 10% acetic acid,
40% methanol). Fractions containing AtxA-His were pooled and dialyzed in 400 mM
NaCl, 5% glycerol, 20 mM Tris pH 7.2, and 5 mM dithiothreitol (DTT).” (102)

2.4 α-AtxA Antibody and AtxA Western blots
“Antiserum for Western blotting was raised in rabbits (Cocalico Biologicals,
Inc., Reamstown, PA). AtxA-His, purified from E. coli using a method similar to that
described above, was injected into rabbits and serum was collected on day 56. To
remove non-specific antibodies, the serum was adsorbed to an immobilized E. coli
lysate (Thermo Scientific) using the manufacturer’s protocol. IgG in the serum was
purified using Pierce Nab Spin Columns (Thermo Scientific).
“B. anthracis cell lysates for Western blotting analysis were obtained from
cultures at early stationary phase (OD600 = 1.2 to 1.7). Culture samples (4 ml) were
centrifuged as described above. After washing cells two times in KTE-PIC (10 mM
Tris-HCl pH 8.0, 100 mM KCl, 10% ethylene glycol, and EDTA-free Complete
proteinase inhibitor), cells were resuspended in KTE-PIC to a final volume of 850 µl
and transferred to a 1.5-ml screw-cap tube containing 400 µl 0.1 mm Zirconia/Silica
Beads (BioSpec Products, Bartlesville, OK). The samples were lysed mechanically
for 2 min using a Mini BeadBeater (BioSpec Products). After centrifugation, soluble
material was mixed with SDS loading buffer (final concentration of loading buffer was
5% glycerol, 100 mM DTT, 2% SDS, 40 mM Tris-Cl pH 6.8), boiled, and subjected to
sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE).
“Prior to protein transfer, gels were equilibrated in CAPS Buffer (10 mM CAPS
pH 11.0, 10% methanol). Using a Hoefer transfer unit (Hoefer, Inc., Holliston, MA)
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containing CAPS Buffer, proteins were transferred to Immobilon-P membrane
(Millipore, Billerica, MA) at 50V at 4° C for 1.5 to 2 h. Membranes were blocked with
TBS-T (20 mM Tris base, 137 mM NaCl, 0.1% Tween 20 [pH 7.6]) containing 5%
non-fat dry milk. Membranes were subsequently treated with primary antibodies (αAtxA, α-RNA polymerase β subunit [Santa Cruz Biotechnology, Santa Cruz, CA], αTHE His [Genscript, Piscataway, NJ], and α-FLAG M2 [Sigma Aldrich]) in TBS-T.
After washing with TBS-T, membranes were finally treated with the corresponding
secondary antibody (goat α-rabbit–HRP conjugate or goat α-mouse-HRP conjugate
[Bio-Rad]).

Blots

were

developed

using

the

SuperSignal

West

Dura

Chemiluminescent Substrate (Thermo Scientific). For re-probing, membranes were
stripped using Restore Western Blot Stripping Buffer (Thermo Fisher) or 62.5 mM Tris
pH 6.8 containing 2% SDS and 100 mM β-mercaptoethanol.” (102)

2.5 Limited Proteolysis
AtxA-His was cleaved with trypsin and chymotrypsin. 30 µg AtxA-His was combined
with 0.3 µg trypsin or chymotrypsin in 100 mM Tris-Cl pH 8.5, 1 mM CaCl2. The digestion
reaction was incubated at 25° C for 4 h and quenched by adding 190 mM Tris-Cl pH 6.8, 4.3
M β-mercaptoethanol, 6% SDS, 3 mM PMSF and boiling for 3 min. AtxA-His fragments were
separated via electrophoresis through 16% polyacrylamide-SDS gels and detected with
Coomassie stain. The 40-kDa band was excised from the gel and digested to completion
with trypsin.

The polypeptide fragments were identified via mass spectrometry in the

laboratory of William Dubinsky at the University of Texas Health Science Center – Houston.
A similar experiment was performed except the proteins were transferred to a PVDF
membrane in 10 mM Tris Base, 100 mM glycine, 10% methanol. I stained the membrane
with 0.1% Coomassie, 40% methanol, and 10% acetic acid and destained with 40%
methanol. The amino-terminus of the major cleavage product was identified via Edman
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Degradation and N-terminal sequencing by Richard Cook at the Baylor College of Medicine
Protein Chemistry Core Facility.

2.6 Filter Binding Assay
The affinity of AtxA-His for
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P-labeled DNA probes was determined using a filter

binding assay similar to established protocols (113). Promoter regions of the lef (167 bp),
bla1 (267 bp), and papR (169 bp) genes were digested from pUTE749, pUTE756, and
pUTE757, respectively (58), using XbaI and SalI. The probes were dephosphorylated during
a reaction with calf intestinal alkaline phosphatase, PNK-treated to label with γ-32P-ATP, and
isolated with Micro Bio-Spin 30 Chromatography columns (Bio-Rad) according to the product
manuals.
The DNA probes (3 pM) and purified AtxA-His (0.01 nM, 0.1 nM, 0.3 nM, 1 nM, 2 nM,
5 nM, 10 nM, 20 nM, 50 nM, 100 nM, 300 nM, and 1000 nM) were diluted in 10 mM Tris-Cl
pH 7.5, 150 mM KCl, 5 mM MgCl2, 5 mM DTT, 3% glycerol, and 0.1 mg ml-1 bovine serum
albumin (BSA). In a 96-well plate, 220 µl reactions were prepared in triplicate. Protein and
DNA solutions were incubated at room temperature for 30 min.

A nitrocellulose filter

membrane was pre-wetted in 150 mM KCl, 10 mM Tris-Cl pH 7.5, 5 mM MgCl2, and 3%
glycerol and placed within a 96-well vacuum manifold. Aliquots of 150 µl of the reaction were
applied to the filter. Subsequently, the filter was dried at 37° C and protein-32P-labeled DNA
complexes were detected via phosphor-imaging screen (Fujifilm, Tokyo, Japan). The images
were scanned via a STORM imager (Amersham Pharmacia Biotech, Piscataway, NJ) and
the intensity of each sample was quantified via ImageQuant software (Amersham Pharmacia
Biotech). The signal intensity minus the background of triplicate samples was averaged and
then normalized to the sample containing 1000 nM AtxA-His.
When varying the KCl concentration or pH, the experiment was performed as
described except with minor modifications. Only 0.2 nM, 20 nM or 200 nM AtxA-His was

30

assayed in each condition.

The membranes were pre-wetted with buffer containing the

lowest salt concentration or lowest pH. Before applying the samples to the filter, the wells of
the vacuum manifold were rinsed with buffer of the corresponding sample.

2.7 BN-PAGE assay
“To perform Blue Native polyacrylamide gel electrophoresis (BN-PAGE),
protein samples mixed with NativePAGE Sample Buffer containing 5% G-250 Sample
Additive were electrophoresed using NativePAGE Novex 4-16% Bis-Tris Gels in the
XCell Surelock Mini-Cell electrophoresis unit according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA). Electrophoresed proteins were transferred to
PVDF at 20V overnight at 4° C. Blots were fixed with 8% acetic acid for 15 min prior
to probing with α–AtxA antibody as described above.” (102)

2.8 Co-affinity purification
“B. anthracis UT376 containing vectors encoding AtxA-His (pUTE991), AtxAFLAG (pUTE992), or GFP-FLAG (pUTE1013) were cultured independently. Three
pools, containing 20 ml of each culture, were collected:

UT376 (pUTE991) and

UT376 (pUTE1013); UT376 (pUTE991) and UT376 (pUTE992); and UT376
(pUTE992) and UT376 (pUTE1013). The cells were washed with 10 ml Binding Buffer
containing EDTA-free Complete proteinase inhibitor (BB-PIC).

Pellets were flash

frozen in an ethanol-dry ice bath and stored at -80° C.
“To create cleared soluble cell lysates, samples were thawed in an ice bath,
resuspended in 2.5 ml BB-PIC, and transferred to two 1.5-ml screw cap tubes, each
containing 500 µl 0.1 mm Zirconia/Silica beads. The samples were lysed
mechanically for 1 min using a Mini BeadBeater, placed on ice for 5 min, and then
subjected to an additional 1 min of bead beating. Following centrifugation at 10,000 x
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g for 5 min at 4° C, the soluble material was incubated at 37° C for 20 min. NTA-Ni
resin (70 µl) was added and the samples were incubated at 4° C for 2 h. The resin
was transferred to spin filters (EMB Chemicals, Darmstadt, Germany) and several
500-µl washes were performed in the following sequence: 2x Binding Buffer, 2x Wash
Buffer 1, 1x Wash Buffer-High Salt, 2x Wash Buffer 1, 1x Wash Buffer 2, and 2x
Wash Buffer 1. Proteins were eluted from the column using 125 µl Elution Buffer and
then denatured with SDS loading buffer. Samples were probed with α-AtxA, α-His,
and α-FLAG antibodies using Western blotting.” (102)

2.9 BMH Cross-linking
“Protein cross-linking was performed as described elsewhere (114). Briefly,
cultures containing UT376 (pUTE658) were induced with 30 µM IPTG for 2 h. Cells
were washed twice with 5 ml phosphate-buffered saline (PBS) containing 10 mM
EDTA and adjusted to pH 7.2. Cells were then resuspended in 1 ml PBS 10 mM
EDTA pH 7.2 and lysed. For each experiment, 250 µl of cleared soluble cell lysate,
representing 5 ml of culture, was mixed with 5 µl of 20 mM bis(maleimido)hexane
(BMH, Thermo Scientific, prepared freshly in DMSO) and incubated at 4° C for 2 h
with end-over-end mixing. Control reactions lacking BMH contained the DMSO
solvent only. Reactions were quenched by adding 40 mM cysteine, vortexing for 10
min, and boiling in the presence of 1X SDS loading buffer containing 100 mM DTT.
The samples were analyzed on 4-15% polyacrylamide SDS gels (Bio-Rad) and AtxA
was detected via Western blotting. ImageJ software (115) was used to determine
relative intensities of cross-reactive bands.
“AtxA-His for cross-linking experiments was affinity purified using NTA-Ni resin
and washes were performed with solutions made without β-mercaptoethanol. AtxA-
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His was eluted from the resin, and subjected to BMH cross-linking as described
above.” (102)

2.10 Purification of EI, HPr, and PEPCK
EI-His and HPr-His were isolated separately from B. anthracis following previously
published methods (116, 117).

Two 2-L baffled flasks containing 500 ml LB medium

inoculated with an eight-hour culture of ANR-1(pUTE1032) or ANR-1(pUTE1040) were
incubated at 37° C. During late exponential phase of growth (OD600 = 0.6 – 0.8), the cultures
were induced with 0.5 mM IPTG at for four hours. Cell pellets were frozen after harvesting
via filtration onto a nitrocellulose membrane (0.22 µm pore-size) and centrifugation at 6200 x
g for 10 min at 4° C. Each cell pellet was resuspended in 10 ml Buffer A-PIC (20 mM Tris-Cl
pH 8.0, 100 mM NaCl, 5% glycerol, 30 mM imidazole pH 7.9, 1X EDTA-free Complete
proteinase inhibitor cocktail) supplemented with 1 mM MgCl2 and 10 units DNAse I. Cells
were lysed via three passages through a French Pressure Cell Press and soluble material
was obtained following centrifugation at 30,000 x g for 20 min at 4° C. Lysates were added
to 1 ml NTA-Ni resin in Buffer A-PIC (total volume of 10 ml) and the suspension was mixed
gently for 2 h at 4° C. The resin was washed in batch three times with 4 ml of Buffer A-PIC.
The resin was transferred to a gravity column and washed with 5 ml Buffer A-PIC. Upon
addition of 5 ml Buffer E (20 mM Tris-Cl pH 8.0, 100 mM NaCl, 5% glycerol, 200 mM
imidazole pH 7.9), 500 µl fractions were collected. Protein concentration and purity of the
fractions were assessed using the Bradford reagent and SDS-PAGE with Coomassie
staining. Fractions containing EI-His or HPr-His were pooled, concentrated, and desalted
using Microcon centrifugal concentrators (Millipore). The proteins were stored at 4° C in 50
mM Tris-Cl pH 7.4, 5 mM MgCl2, 5% Glycerol.
PEP carboxykinase (His-PEPCK) was expressed and purified from the E. coli strain
C41(DE3) harboring plasmid pKSM879 (gift from K. McIver, University of Maryland).

A

33

colony of the strain was used to inoculate three 2-L baffled flasks each containing 500 ml
ZYP-5052 autoinduction medium (118). The cells were cultured at 37° C for 24 hours. After
harvesting cells via centrifugation (10 min, 6200 x g, 4° C), the cell pellet was washed twice
with 50 ml 100 mM NaH2PO4 pH 8.0 and stored at -80° C. The cell pellet was resuspended
in 35 ml Buffer 1 (20 mM imidazole, 20 mM NaH2PO4, 500 mM NaCl, pH 7.4) containing
Complete EDTA-free proteinase inhibitor and cell membranes were ruptured during five
passages through a French Pressure Cell. The sample was centrifuged at 6200 x g at 4° C
for 10 min. The soluble material was transferred to a new tube and centrifuged for 20 min at
20,000 x g and 4° C before applying to 2 ml NTA-Ni resin prewashed with Buffer 1. After
binding for 1 h at 4° C, the resin was washed in batch using 8 ml Buffer 1. The resin was
transferred to a gravity-flow column and subsequently washed with 25 ml Buffer 1. PEPCK
was eluted from the resin with 10 ml Buffer 2 (500 mM imidazole, 20 mM NaH2PO4, 500 mM
NaCl, pH 7.4). 20 µl Ni chelation buffer (250 mM EDTA, 50 mM NaH2PO4) was added per ml
fraction and fractions containing His-PEPCK were dialyzed four times against 1 L Buffer 3
(20 mM Tris-Cl pH 7.4, 1 mM EDTA, 100 mM KCl). The induction and purification yielded
100 mg His-PEPCK.

2.11 Synthesis of 32P-PEP
32

P-PEP was synthesized and isolated according to methods established previously

(119) using γ-32P-ATP (PerkinElmer, Waltham, Massachusetts) and PEPCK.

0.5 ml

reactions containing 50 mM HEPES pH 7.5, 12.5 mM KF, 5 mM MgCl 2, 1 mM oxaloacetate,
500 µg PEPCK, 50 µM γ-32P-ATP (2 mCi ml-1, 10 Ci mmol-1) were incubated for 5 min at
room temperature (21° C). The reaction was diluted 10-fold with ddH2O, and the newly
synthesized
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P-PEP was isolated via anion exchange chromatography using AG-1-X8

Bicarbonate resin. The hydroxide form of the AG-1-X8 resin (BioRad) was converted to the
bicarbonate form according to the product manual. The PEP reaction was added to 2 ml of

34

resin and 32P-PEP was eluted using a step-wise gradient consisting of 5 ml 0.3 M, 0.4 M, 0.6
M, and 0.7 M triethylammonium bicarbonate.
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P-PEP was present in fractions containing

0.6 M and 0.7 M triethylammonium. The fractions were concentrated 5 fold via vacuum
centrifugation in a vacufuge (Eppendorf, Hamburg, Germany).

2.12 In vitro Phosphotransfer Assay
Phosphotransfer assays were conducted using purified EI-His, HPr-His, and AtxAHis. Reactions contained 3 µg EI-His, 1.6 µg HPr-His, 2 µg AtxA-His in a total volume of 30
µl buffer (50 mM Tris-Cl pH 7.4, 5 mM MgCl2). 32P-PEP (0.5 µCi, 10 Ci mmol-1) was added to
a final concentration of 10 µM and the solutions were incubated for 30 min at 37° C.
Reactions were quenched by adding SDS loading buffer (final concentration of loading buffer
was 5% glycerol, 100 mM DTT, 2% SDS, 40 mM Tris-Cl pH 7.4). Samples were subjected to
SDS-PAGE (12% poly-acrylamide SDS gel). The gels were dried and exposed to phosphorimaging screen to detect
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P-labeled protein. The screens were scanned using a STORM

840 scanner and analyzed with ImageJ software.
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Chapter III
Analysis of the domains and DNA binding properties of AtxA, the
virulence gene regulator of B. anthracis.
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3.1 Introduction
B. anthracis virulence gene regulation requires AtxA, a protein encoded on the
extrachromosomal virulence plasmid pXO1. In atxA mutant strains, toxin gene expression
and capsule biosynthesis, the major B. anthracis virulence traits, are decreased severely and
the organism is attenuated (46, 47, 49–54). The molecular function of AtxA is unknown;
however, a model has been proposed that AtxA contains two functional regions (60). The
amino-terminus of AtxA is predicted to bind DNA promoters via two putative DNA-binding
elements. DNA-binding activity of AtxA is controlled via structural changes occurring within a
regulatory region containing the carboxy-terminal PRDs and EIIB-like motifs (AtxA motifs are
introduced in section 1.4).
The amino acid sequence of AtxA indicates that two types of helix-turn-helix motifs
are present within the putative DNA-binding region: a winged helix-turn-helix (WH) and a
classical helix-turn-helix (HTH). HTH motifs are the most common DNA-binding modules
used in bacteria (120). Consisting of approximately 20 amino acids, HTH motifs contain two
α-helices separated by a four-residue loop creating a 120° turn (121). The second helix is
the recognition helix which binds the major groove of DNA forming base-specific contacts
(122). Mutations in the recognition helix can disrupt DNA binding without altering the stability
of the protein (91). The prototypical WH is arranged H1-S1-H2-H3-S2-W1-S3-W2.

The

HTH in the WH is H2 and H3, while the wings (W1 and W2) are loops which form between
and after anti-parallel β sheets (S2 and S3) (123). The wings can contact the phosphate
backbone or make specific hydrogen bonds to the DNA. There are examples of the wings
facilitating protein-protein interactions (124, 125). Interestingly, WH motifs are known to
undergo disorder-to-order shifts when small molecule cofactors are present (126).

The

classical HTH within AtxA has strong similarity to HTH-4 of Mga (see section 1.6 for an
introduction to Mga).

Mga HTH-4 binds specifically to DNA probes in electrophoretic
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mobility shift assays (90, 91). Even with two putative DNA-binding motifs, AtxA has not been
shown to bind specifically to target promoters.
Most DNA-binding proteins bind to a specific nucleotide sequence; however, a few
proteins bind to unique structural elements within the DNA (127). The toxin gene promoters
display no sequence similarity. Hadjifrangiskou and Koehler (58) determined the minimal
functional promoters for the toxin genes, pagA, lef, and cya.

No consensus sites were

detected within these regions which ranged from 137 to 168 bp in length; however, the A+T
content was significantly higher for the toxin gene promoters (79-85%) than the B. anthracis
genome (64.6%, (4)). Considering high proportions of A+T bases indicate a high level of
DNA curvature, Hadjifrangiskou and Koehler provided in vitro and in silico evidence that the
pagA, lef, and cya promoters form 90° bends and distinct kinks. Given this information, AtxA
may bind to a structural feature within the DNA and not a specific sequence.
One way to study protein-DNA interaction and the function of individual motifs within
a protein is to investigate the domain organization of a protein via limited proteolysis and
express each domain or motif independently. LicT, a B. subtilis protein containing an RNA
binding motif and two PRDs, was studied using limited proteolysis and protein truncations.
Data from limited proteolysis experiments suggested there are two major domains within the
protein (128).

When the motifs were expressed in isolation, each one was capable of

maintaining some functional activity. The PRDs formed a homodimer and the RNA binding
motif bound its RNA target sequence (129).
In this chapter, I describe a system for over-expression of AtxA in B. anthracis that
allowed me to uncouple transcriptional control of atxA expression from in vivo studies of
protein function. I present results from limited proteolysis experiments suggesting proteaseresistant domains. The activity of truncated versions of AtxA, missing one or more motifs, in
parent and atxA-null strains is assessed. Lastly, I determine the DNA binding affinity of AtxA
and measure the effects of KCl concentration and pH on the degree of DNA binding.
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3.2 Results
3.2.1 Induction of AtxA in B. anthracis
To study AtxA protein function in vivo, it is desirable to over-express the protein within
B. anthracis.

The atxA gene is subject to complex transcriptional control (Fig. 1-1).

Moreover, the amount of AtxA in each cell is low (approximately 250 proteins per cell,
Raynor and Koehler unpublished results). To overcome these complications, I developed an
expression system that allows controlled induction of atxA expression resulting in specific
levels of AtxA protein. The induced protein may be purified and used for in vitro analyses or
utilized in vivo to answer questions regarding the function of AtxA. The inducible system was
used in several experiments throughout my dissertation. Here I describe the expression
pattern of AtxA when IPTG is titrated into cell cultures. I also demonstrate that the protein is
functional when over-expressed.
I cloned the atxA gene downstream of the IPTG-inducible hyper-spank promoter
(Phs) on a low-copy plasmid (pUTE657) and determined the amount of AtxA protein and
activity gained in B. anthracis. Phs contains 2 lacO sequences that can bind the plasmidencoded LacI repressor. IPTG binds to LacI to relieve the repression and allow transcription
of the downstream gene. Using Phs-gfp, I determined that there was little variation in the
amount of GFP expression within each cell in the culture indicating that IPTG activates
transcription uniformly (data not shown). The plasmid containing Phs-atxA (pUTE658) was
transformed into an atxA-null mutant of the ANR-1 strain harboring a Plef-lacZ transcriptional
fusion (UT376). During early exponential growth in toxin-inducing medium (CACO3), I added
10-60 µM IPTG to induce expression of atxA. Samples for AtxA Western blots and AtxA
activity assays were collected at the transition to stationary phase (Fig. 3-1A). AtxA activity,
defined by the amount of β-galactosidase activity resulting from expression of the Plef-lacZ
reporter, increased in an IPTG dose-dependent manner (Fig. 3-1B). The AtxA activity in
cultures induced with 10 µM IPTG was similar to the parent strain in which AtxA was
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Figure 3-1. AtxA activity and protein amount after induction with IPTG.
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Figure 3-1. AtxA activity and protein amount after induction with IPTG. A. In an atxAnull strain (UT376), production of AtxA (Phs-atxA, pUTE658) was induced (arrow, 2 h; OD600
0.23 – 0.25) using 10 - 60 µM IPTG during growth in CACO3. The parent strain (UT375)
contained atxA at its native locus. The empty vector sample (EV) was derived from UT376
(pUTE657) that lacks atxA. Samples were obtained at the transition to stationary phase
(arrow; 4 h; OD600 1.2–1.7). B. The β -galactosidase activity of B. anthracis mutants
harboring the Plef-lacZ reporter and IPTG-inducible atxA alleles was determined as
described previously (130), and results from a representative experiment are shown. The
histograms represent the Miller Units. Values, normalized to the parent strain, are shown
above each sample. C. AtxA and RNA Polymerase β subunit in soluble cell lysates were
detected via immunoblotting. The AtxA levels indicated were normalized relative to the
corresponding RNA polymerase β level. D. The AtxA Protein Level of each sample was
plotted in respect to the AtxA Activity. The concentration of IPTG in each culture is present
next to each data point. The line of best fit is shown (R2 = 0.9959).
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produced from its native promoter. Inducing with 40 µM IPTG produced 4.59-fold more
activity, the highest amount of activity detected. Interestingly, AtxA activity did not increase
further when 50 or 60 µM IPTG was added even though the amount of AtxA protein changed.
AtxA protein levels increased upon IPTG addition (Fig. 3-1C). Induction of Phs-atxA
with 10 µM IPTG resulted in AtxA levels equal to the parent strain. Cells produced 23.9
times more AtxA than the parent strain when induced with 50 µM IPTG.

In other

experiments, cells induced with 1 mM IPTG produced approximately 50-fold excess AtxA;
however the cells stopped replicating after adding IPTG (data not shown).
I plotted AtxA protein levels versus AtxA activity and saw a linear relationship
between these two parameters within a defined region (10 – 40 µM IPTG, Fig. 3-1D). These
results demonstrated that the steady state level of AtxA can be increased 25-fold above the
native level and that the induced AtxA is active.

3.2.2 AtxA contains two large domains
Domain organization of the five putative motifs of AtxA is poorly understood. The
structure of AtxA was probed using limited proteolysis, a facile method to detect well-folded
protein domains (131). Proteolytic enzymes cut proteins in regions where the proteasespecific sequences are solvent-accessible and flexible. Tightly-folded domains are resistant
to cleavage, whereas loops between the domains are sensitive.
I digested purified AtxA-His with trypsin and chymotrypsin. AtxA-His was induced in
E. coli and purified to greater than 90% homogeneity. Trypsin cuts after lysine or arginine
residues, and chymotrypsin cleaves primarily after aromatic amino acids.

To prevent

complete digestion of AtxA, I incubated AtxA with a low concentration of protease. Both
proteases released one major product, an approximately 40-kDa fragment of AtxA (Fig. 32A). The tryptic protein fragment was identified via mass spectrometry and amino-terminal
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Figure 3-2. AtxA contains one major protease cleavage site. Affinity-purified AtxA-His
was subjected to limited proteolysis with trypsin (T) and chymotrypsin (C) for 4h at 25° C. A.
Coomassie-stained SDS-PAGE displays the major cleavage product (*). Full-length AtxA
(arrow) is present in all samples, including the untreated control (UNT). B. Using aminoterminal sequencing, the dominant cleavage site after trypsin digest was identified as K140
(underlined).
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sequencing as the last 335 amino acids of AtxA-His (AtxA141-475, Fig. 3-2B). The major site of
cleavage for chymotrypsin was not identified; however it may be Y129, L136, L143, or F155.
These data suggested that AtxA contains two domains. The first domain encompassed the
putative DNA-binding elements (AtxA1-125), while the second consisted of the PRDs and EIIBlike motif (AtxA167-475). The 41 amino acids between the domains (AtxA126-166) may be a
flexible, linker region.

3.2.3 The function of individual motifs of AtxA
The results from the limited proteolysis experiments guided the construction of
several truncated versions of AtxA. As depicted in Fig. 3-3A, the AtxA truncations lack one
or more motifs.

I incorporated a carboxy-terminal FLAG or GFP-FLAG tag on each

derivative of AtxA cloned into the IPTG-inducible vector pUTE657. FLAG-tagged proteins
were distinct from AtxA when using the α-FLAG antibody. GFP-FLAG added 29 kDa and
increased the stability of the truncated versions of AtxA. GFP also permitted the use of
fluorescence microscopy to confirm expression of the protein.
The fragments of atxA were expressed in a parent strain and an atxA mutant
containing the Plef-lacZ reporter (UT375 and UT376, respectively). After induction with 50 or
100 µM IPTG, the proteins were soluble within the cell and present at levels similar to fulllength AtxA (data not shown). The AtxA protein derivatives were not functional in an atxAnull strain as no protein provided Plef-lacZ activity greater than the empty vector control (Fig.
3-3B). These results suggest that all the motifs were necessary for AtxA to function properly.
The activity of native AtxA was not affected by the protein fragments with the exception of
AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG (Fig. 3-3C). Only 40% of the parent strain
activity was detected during expression of these protein fragments, which include the PRDs.
The data suggest that AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG may be dominant
negative and function to titrate a signal from AtxA.

An alternate explanation is that the

44

Figure 3-3. AtxA activity of the AtxA motifs in vivo. A. AtxA contains five putative motifs
as shown in the schematic. Five truncated AtxA proteins (containing one or more of the
motifs fused to FLAG or GFP-FLAG tags on the carboxy-terminus) were placed under the
control of the IPTG-inducible Phs (pUTE657) to make pUTE1018-1022. B. and C. The atxAnull and parent strains harboring Plef-lacZ (UT376 and UT375, respectively) and the AtxA
truncations were cultured in CACO3. Cultures were induced during early exponential phase
and samples were collected at the transition to stationary phase for β-galactosidase activity
assays. Graphs show the β-galactosidase activity normalized to the AtxA-FLAG sample (B,
ΔatxA strain) or to the empty vector (C, Parent strain). Note the change in scale of the yaxes. Cartoons below each bar represent the tagged AtxA fragment induced in each
sample. AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG decrease native AtxA activity
(blue stars).
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fragments prevent full-length AtxA from functioning via protein-protein contacts. Notably,
AtxA1-385–FLAG and AtxA385-475–GFP-FLAG did not diminish AtxA activity. Each of these
AtxA protein truncations contains the PRDs, the EIIB-like motif, or the GFP-FLAG fusion;
therefore, the reason for the dominant negative phenotype is unknown. These data provide
an initial analysis of the function of each AtxA region.

3.2.4 AtxA binds DNA non-specifically
WH and HTH motifs indicate that AtxA binds to specific promoter elements; however,
there does not appear to be a consensus sequence within the promoters of the AtxAregulated toxin genes pagA, lef, and cya (58). To investigate if AtxA interacts directly and
specifically with DNA, I conducted in vitro DNA-binding using filter binding assays.
constant amount of

A

32

P-labeled DNA and increasing concentrations of AtxA-His were mixed

in Tris buffer containing 150 mM KCl at pH 7.5. The protein, which was purified from E. coli,
was bound to a nitrocellulose membrane, and the AtxA-DNA association equaled the
intensity of the radioactive signal.

For DNA probes, I used a promoter from an AtxA-

regulated toxin gene (Plef), promoters from B. anthracis genes that are AtxA-independent
(Pbla1 and PpapR), and sequence from an E. coli expression vector (pET23d). The binding
curves indicated that AtxA binds to all probes with high affinity and no specificity (Fig. 3-4).
The dissociation constant (Kd) of the AtxA-DNA interaction is below 1 nM. A low nanomolar
Kd is significant and suggests that AtxA binds DNA in vivo.
In order to determine if the interaction between AtxA and DNA is facilitated by ionic
interactions, I performed DNA binding assays with different pH or KCl concentrations. AtxA
bound less effectively to the lef promoter and a segment of pET23d as the KCl concentration
increased from 22 mM to 300 mM (Fig. 3-5A). 22 mM KCl promoted the greatest amount of
AtxA-DNA interaction. 300 mM KCl abolished AtxA binding to DNA. Lowering the pH from
7.5 to 6.8 increased the amount of DNA bound by 20 nM AtxA (Fig. 3-5B). AtxA-DNA
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Figure 3-4. AtxA binds DNA non-specifically with high affinity. Filter Binding Assays
were used to probe the interaction between affinity-purified AtxA-His and non-specific control
promoter sequences (Pbla1, 267 bp, and PpapR, 169 bp) or an AtxA-dependent promoter
(Plef, 167 bp). A six-log range of protein concentration was used with a constant amount of
32
P-labeled DNA (0.3 nM) in 150 mM KCl, 10 mM Tris-Cl, 5 mM MgCl2, 5 mM DTT, 3%
glycerol, 0.1 mg/ml BSA, pH 7.5. The radioactive signal from triplicate reactions was
averaged and normalized to the sample containing 1000 nM AtxA. Error bars represent ±1
SD.
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interaction did not change when the pH was increased from 7.5 to 8.5 or 9.1. Altering the
KCl concentration or pH did not result in specific DNA binding. AtxA bound to the target and
control promoters with similar affinities. These data indicate that an AtxA-DNA interaction is
dependent on the KCl concentration; however, increasing pH of the solution above 7.5 did
not have a great effect.

3.3 Discussion
In this chapter, I have described the IPTG-inducible system for AtxA expression in B.
anthracis, analysis of the domain organization and motifs of AtxA, and an initial
characterization of the DNA binding properties of AtxA.
Expression of atxA using a heterologous promoter led to a 25-fold higher AtxA
concentration and a 4.5-fold increase in Plef-lacZ expression.

Preliminary experiments

performed by others in our laboratory indicate that there are as few as 250 AtxA molecules
per cell when AtxA is expressed from its native promoter (unpublished 2010). The low level
of AtxA makes it challenging to detect the protein in B. anthracis cells. Controlling AtxA via
an IPTG-inducible promoter allows over-expression of AtxA-His for purification, production of
mutant forms of AtxA (point mutations and truncated versions), and induction of AtxA in
conditions that do not favor AtxA activity.
The relationship between AtxA protein level and AtxA activity suggests that AtxA is
limiting for lef expression. Induction of AtxA with 10 µM IPTG produced native levels of AtxA
protein and activity, and a slight increase in IPTG concentration led to increased AtxA and
Plef-lacZ expression. Control experiments showed that IPTG did not induce expression of
the toxin genes in the parent strain (lacks Phs-atxA). Therefore, elevated Plef-lacZ upon the
addition of IPTG to cells containing the Phs-atxA was due to higher AtxA protein levels. If
AtxA was not limiting, increased AtxA protein would not lead to higher lef transcript levels.
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Figure 3-5. AtxA-DNA binding is sensitive to KCl concentration but not to pH. Affinitypurified AtxA-His and Plef (167 bp) or a control DNA probe (179bp of the plasmid pET23d)
were subjected to Filter Binding Assays. 0.2 nM, 20 nM, or 200 nM AtxA was mixed with a
standard amount of 32P-labeled DNA (0.3 nM) in 150 mM KCl, 10 mM Tris-Cl, 5 mM MgCl2, 5
mM DTT, 3% glycerol, 0.1 mg/ml BSA, pH 7.5. A. The concentration of KCl was changed to
22 mM, 75 mM, 150 mM, or 300 mM. B. AtxA-DNA interactions were probed in a Tris buffer
at pH 6.8, 7.5, 8.5 or 9.1. Each column represents the average radioactive signal minus the
background signal (DNA alone) of an experiment done in duplicate. Error bars represent ±1
SD.
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Although AtxA may be a limiting factor for toxin gene expression under native
conditions, the data also suggest that AtxA does not act independently. Soluble AtxA protein
levels increased from 14.5 to 23.9 times the parent concentration between 40 and 50 µM
IPTG; however, AtxA activity plateaued when cells were induced with 40, 50, or 60 µM IPTG.
If AtxA acted independently, then I would expect AtxA activity to be highest in cultures
induced with 50 µM IPTG. I was not able to determine the identity of the limiting factor in the
process when AtxA activity is at its maximum. Two possible explanations are that Plef-lacZ
transcription rate may be at its maximum or the cellular amount of a post-translational signal,
ligand, or binding protein may have been exhausted.
The IPTG-inducible promoter allows the study of the AtxA motifs by expressing
truncated forms of AtxA. As I describe in the introduction (section 1.7), I favor a model in
which AtxA contains two functional domains. The amino-terminal region appears to bind
DNA, and the remainder of the protein regulates the DNA binding activity.

Limited

proteolysis supports this model: the final 335 amino acids of AtxA are resistant to digest with
trypsin or chymotrypsin. Due to the numerous trypsin cut sites (58 in total, 39 downstream of
the dominant site of digestion K140), AtxA is expected to be completely digested during an
extended reaction. The 40-kDa product could only be present if that region of the protein
was a well-folded domain where trypsin could not cleave.
The protease-resistant AtxA fragment contains two PRDs and an EIIB-like motif.
When I expressed these motifs fused to a carboxy-terminal GFP-FLAG tag (AtxA167-475–GFPFLAG) in an atxA-null strain, little lef expression was detected from the Plef-lacZ reporter. In
the parent strain, AtxA167-475–GFP-FLAG decreased the amount of AtxA activity by 60%.
AtxA167-385–GFP-FLAG, which contains only the PRDs, displayed a similar phenotype. These
data suggested that while the PRDs were not capable of complementing atxA, they were
able to produce a dominant negative phenotype in the parent strain.
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Why were the PRDs able to cause a decrease in toxin gene expression in the parent
strain? One possible explanation is that the PRDs (with or without the EIIB motif) could
complex with AtxA or another protein. In Chapter 4, I describe experiments which indicate
that AtxA forms a homomultimer in vivo, and I propose that the EIIB-like motif facilitates
AtxA-AtxA interactions. A second explanation for the dominant negative phenotype is that a
signal was titrated from AtxA by AtxA167-385–GFP-FLAG and AtxA167-475–GFP-FLAG. The
protein(s) that phosphorylate H199 and H379 may modify the protein fragments instead of
full length AtxA.

In this scenario, the PRDs would serve as phosphate sinks.

Future

experiments are needed to understand fully why AtxA167-385–GFP-FLAG and AtxA167-475–GFPFLAG caused a dominant negative phenotype. One confounding factor is that AtxA1-385,
containing the DNA binding motifs and the PRDs, did not reduce the activity of AtxA in the
parent strain. I speculate that AtxA1-385 does not exhibit a dominant negative phenotype
because the DNA-binding motifs disrupt the protein-protein interaction and/or ligand binding.
Included in AtxA1-138 are the amino-terminal WH and/or HTH which are predicted to
bind DNA. The protein fragment failed to complement an atxA-null strain suggesting that the
motifs require the rest of the protein to function properly. Alternatively, the truncation could
have been misfolded. Although it is unknown if AtxA1-138 binds DNA in vivo, the protein can
be tested using the filter binding assay.
Purified AtxA-His bound without sequence specificity to DNA with sub-nanomolar
affinity in a filter binding assay. The binding affinity of the AtxA-DNA interaction is quite
significant as other specific DNA binding proteins have affinities less than 10 nM (132, 133).
Mga and MtlR are proteins with motifs similar to AtxA and bind specifically to DNA. MtlR
binds to five regions spanning 45 bp upstream of the -35 consensus sequence within a target
promoter (84). The DNA binding affinity of MtlR changes from 3.4 nM to 1300 nM depending
on the phosphorylation state of MtlR. Similar to MtlR, Mga specifically binds to several
promoters and protects a 45 bp region adjacent to the -35 consensus sequences of the emm
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and scpA6 genes (90). The studies with MtlR and Mga suggest that specific conditions
within the experiment (pH or salt) or mutated versions of AtxA can be determined to promote
specific DNA binding.
I altered the salt concentration and pH of the experiment and determined that the
DNA binding affinity of AtxA decreased as the KCl concentration increased. Changing the
ionic strength of the buffer may have interfered with AtxA contacts on the phosphate
backbone of the DNA. Protein-phosphate interactions are DNA sequence-independent by
nature, because any positively charged amino acid can interact with the anionic phosphate.
However, several DNA-binding proteins contact the phosphate backbone to increase the
stability of the protein-DNA complex (126).

My results show that disrupting the ionic

interactions between AtxA and DNA has a major effect on the binding properties of AtxA.
On the other hand, changing the pH of the reaction did not have a severe effect. The
affinity of AtxA to DNA increased at pH 6.8.

A dose-dependent binding curve was

established independent of the pH (from 6.8 to 9.1). This was surprising, since changing the
pH will change the net charge of AtxA. The isoelectric point (pI) of AtxA is predicted to be
9.3. The net charge of AtxA is ~14 at pH 6.8, ~12 at pH 7.5, ~ 7 at pH 8.5, and ~3 at pH 9.1.
The pI of the DNA binding region of AtxA (residues 1-164) is 9.73; therefore the net charge of
the region would be slightly greater than full length AtxA. These results suggest that there
are sequence-specific sites of AtxA-DNA interaction.
The filter binding assays have shown that AtxA has a high affinity for DNA and that
the AtxA-DNA affinity can be altered with KCl, but not pH. However, AtxA bound to DNA
non-specifically in this assay.

As you will see in the coming chapters, AtxA forms a

multimeric structure in specific growth conditions (elevated CO2/bicarbonate) and
phosphorylation of AtxA affects the activity of AtxA. Could a ligand or post-translational
modification be needed for AtxA to interact to only its target promoters? Future experiments
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should use AtxA point mutations that mimic phosphorylation and utilize buffer conditions that
contain potential AtxA ligands.
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Chapter IV
The B. anthracis virulence regulator AtxA: oligomeric state,
function, and CO2-signaling

NOTE: This chapter is derived from work that, for the most part, has been published in 2011:
“The Bacillus anthracis virulence regulator AtxA: oligomeric state, function, and CO2signaling.” Molecular Microbiology 82(3): 634-47 PMID:21923765. I am the primary author on
this paper. I performed all experiments described in this chapter. I have received permission
by the publisher of Molecular Microbiology, John Wiley and Sons, to reproduce all of the
manuscript in print or electronically for the purposes of my dissertation (License Number:
2796030226674)
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4.1 Introduction
Regulation of protein function can occur in the form of modulation between a nonactive state and an active form of the protein. In several cases, the transition between each
state is mediated via post-translational modification and/or ligand binding which induce
changes to the protein structure.

Protein multimerization may result from the altered

structure. Understanding the forms of a protein in vivo provides clues to the function of the
protein and the mechanism(s) needed to activate the protein. For example, dimerization of
the PRD-containing proteins, LicT and BglG, is affected by phosphorylation (79, 80, 128,
134). LicT, when phosphorylated within PRD2, forms a homodimer due to stabilization of the
complex via salt bridges forming between the phosphohistidine residues and two arginines
(135). Conversely, phosphorylation of PRD1 prevents dimerization via electrostatic repulsion
between the phosphohistidines and a glutamic acid residue. The regulation of the form and
function of LicT provides the impetus for me to study the multimeric state of AtxA, the PRDcontaining virulence gene regulator of B. anthracis.
“The molecular basis for AtxA function as a positive regulator of B. anthracis
virulence genes has not been established. As described in section 1.4, the amino
acid sequence of AtxA reveals a number of motifs associated with potential functional
domains. The amino terminal region of the protein contains adjacent winged helix and
helix-turn-helix (HTH) motifs. The central region of the AtxA amino acid sequence
reveals

motifs

suggesting

two

phosphoenolpyruvate:carbohydrate

phospho-

transferase system (PTS) regulation domains (PRDs). PRDs are generally found in
bacterial proteins that function to activate or anti-terminate transcription of genes
involved in the metabolism of specific carbohydrates (73). Transcriptional profiling
studies have not revealed AtxA targets associated with catabolism (57), but
Tsvetanova et al. (59) reported that phosphorylation of specific histidine residues,
H199 and H379, each within a PRD, impacts AtxA activity.
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“A key host-related signal associated with AtxA-regulated gene expression is
CO2/bicarbonate. Growth of B. anthracis in 5% or greater atmospheric CO2 in
buffered medium results in elevated transcription of the toxin, capsule, and other
AtxA-regulated genes (47, 49, 50, 69–71). Some studies suggest that the
CO2/bicarbonate effect on toxin genes occurs in an atxA-dependent manner (47, 54,
64, 72), yet the signal does not appear to significantly affect steady state levels of
atxA transcript or AtxA protein (64, 95). Moreover, a protein-ligand relationship
between CO2/bicarbonate and AtxA has not been established, nor have additional
proteins associated with AtxA function been identified.
“In this chapter I provide data indicating that AtxA exists in a homo-oligomeric
state and that AtxA-AtxA contacts occur within a previously uncharacterized carboxyterminal EIIB-like motif. I also show a correlation between growth in elevated
CO2/bicarbonate, the steady state level of AtxA multimer, and AtxA activity.” (102)

4.2 Results
4.2.1 AtxA activity in vivo
“AtxA is a cytoplasmic protein with a predicted MW of 55.6 kDa (46). Some
functional domains have been postulated (59, 60); however, the structure of AtxA has
not been solved. Moreover, the multimeric state of AtxA in vivo and whether AtxA
associates with other B. anthracis proteins, have not been discerned.
“Expression of the atxA gene is highly regulated. Therefore, to investigate
AtxA form and function in vivo, I developed a system to control AtxA protein levels
and quantitatively assess AtxA activity in B. anthracis. Alleles of atxA encoding native,
mutant, and C-terminal epitope-tagged versions of the protein were cloned such that
expression was under control of the IPTG-inducible hyper-spank promoter on a low
copy number plasmid, pUTE657. Recombinant epitope-tagged proteins, AtxA-His and
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AtxA-FLAG, facilitated immuno-detection and purification from B. anthracis. AtxA
positively controls transcription of multiple genes in B. anthracis, although a direct
interaction of the AtxA protein with promoters of target genes has not been
demonstrated. One of the genes most strongly regulated by AtxA is lef, encoding the
lethal factor protein, a component of the anthrax toxin (57). Plasmids bearing IPTGinducible atxA alleles were introduced into a B. anthracis strain (UT376) which
harbors a markerless deletion of atxA and a transcriptional reporter, Plef-lacZ, at the
native lef locus on pXO1. AtxA activity was quantified by measuring β-galactosidase
activity following IPTG induction of the atxA alleles.
“Strains were cultured in CACO3 in a 5% CO2 atmosphere, conditions shown
previously to be conducive for atxA-controlled toxin gene expression (49). Figure 4-1
shows relative AtxA levels and activities in B. anthracis cultures expressing native
AtxA, AtxA-His and AtxA-FLAG. RNA polymerase β subunit was used as a loading
control. Induction with 30 µM IPTG yielded levels of epitope-tagged proteins that were
comparable to untagged AtxA (Fig. 4-1A), indicating that protein stability was
unaltered by the C-terminal His- and FLAG-tags. The cultures also displayed similar
levels of β-galactosidase activity (Fig. 4-1B), indicating that the recombinant proteins
do not exhibit altered function. The amount of induced AtxA is 8.5-fold greater than
the level of AtxA expressed from its native promoter on pXO1 and results in 3-fold
more β-galactosidase activity (data not shown). Notably, expression of the Plef-lacZ
fusion in the atxA-null strain containing the empty vector (pUTE657) was barely
detectable, confirming previous reports that transcriptional control of the lef gene is
highly dependent upon AtxA (46, 49).” (102)
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Figure 4-1. In vivo activity of AtxA-His and AtxA-FLAG. In an atxA-null strain (UT376),
production of AtxA (pUTE658), AtxA-His (pUTE991) and AtxA-FLAG (pUTE992) was
induced using 30 µM IPTG during growth in CACO3. The empty vector sample (EV) was
derived from UT376 (pUTE657) that lacks atxA. Samples were obtained at the transition to
stationary phase (4 h; OD600 1.2–1.7). A. AtxA and RNA Polymerase β subunit in soluble
cell lysates were detected via immunoblotting. The AtxA levels indicated were normalized
relative to the corresponding RNA polymerase β level. B. The β -galactosidase activity of B.
anthracis mutants harboring the Plef-lacZ reporter and IPTG-inducible atxA alleles was
determined as described previously (130). Error bars represent ±1 SD.
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4.2.2 Multimerization of AtxA
“In vivo AtxA – protein interactions are of interest because DNA-binding
proteins and proteins containing PRDs often function as dimers (79, 80, 126, 128,
134). Furthermore, some investigations have suggested that an additional factor is
required for AtxA function (47, 59). To explore possible protein-protein interactions, I
subjected lysates from B. anthracis strains producing native AtxA to Blue Native
PAGE (BN-PAGE) to determine the migration pattern of AtxA in native conditions.
Electrophoresed proteins were transferred to membranes and probed with α-AtxA
antibody.

The mobility of immuno-reactive bands relative to molecular weight

markers suggested that AtxA was in a complex (Fig. 4-2A).
“To test for stable interactions between AtxA and other cytosolic proteins, I
subjected cell lysates of B. anthracis cells producing AtxA-His to affinity purification
using NTA-Ni resin. Purified AtxA-His was analyzed using BN-PAGE and denaturing
PAGE. Western hybridization using α-AtxA serum revealed three major bands
migrating at approximately 110 kDa, 225 kDa, and > 225 kDa and a minor band
migrating at approximately 60 kDa (Fig. 4-2A). In contrast, Coomassie staining after
SDS-PAGE revealed only one band in the AtxA-His eluate and its gel mobility was
consistent with the size of an AtxA-His monomer (56 kDa) (Fig 4-2B). Since no other
proteins were detected in the AtxA-His eluate via SDS-PAGE and the protein
mobilized as multiple species on BN-PAGE, these results suggested that AtxA forms
multiple homomeric complexes in cell lysates.
“To detect association of two or more monomers of AtxA, I combined culture
lysates of B. anthracis strains producing AtxA-His or AtxA-FLAG and used affinity
chromatography to purify AtxA-His. A lysate from a B. anthracis strain producing
GFP-FLAG was used as a control. Lysates were derived from pools of cultures
containing (1) AtxA-His and GFP-FLAG, (2) AtxA-His and AtxA-FLAG, and (3) AtxA-
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Figure 4-2. Oligomeric states of AtxA. (A) Lysates from B. anthracis strains UT376
(pUTE657) and UT376 (pUTE658), containing an empty vector (EV) and IPTGinducible atxA respectively, and affinity-purified AtxA-His were electrophoresed on BN
polyacrylamide gels. AtxA protein was detected using Western blotting. M = molecular
weight markers (ProSieve Unstained Protein Marker, VWR). (B) Affinity purified AtxAHis from B. anthracis UT376 (pUTE991) was subjected to SDS-PAGE and stained
with Coomassie. M = molecular weight markers (SeeBlue Plus2 Pre-Stained
Standard, Invitrogen).
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FLAG and GFP-FLAG. Proteins were captured using NTA-Ni resin, eluted with
imidazole, and detected by Western blotting. As shown in Figure 4-3 (lanes 1-3), prior
to affinity purification each tagged protein was detected in the appropriate pools.
Eluates from NTA-Ni resin are shown in lanes 4-6. AtxA-FLAG was detected in the
eluate only when combined with AtxA-His (lane 5). GFP-FLAG served as a negative
control to ensure that non-specific proteins were washed from the NTA-Ni resin and
that the His and FLAG tags did not interact. These results demonstrate that AtxA-His
and AtxA-FLAG form a stable complex in vitro. Considering these data and the results
from BN-PAGE, I conclude that AtxA self-associates to form dimers, tetramers, and
higher MW species.” (102)

4.2.3 Role of the carboxy-terminal region of AtxA in multimerization
“To further explore the properties of AtxA multimerization, I tested for the
ability of the cross-linking reagent BMH to covalently fix AtxA complexes in cell
lysates. BMH reacts specifically and irreversibly to link cysteine residues within 13Å.
AtxA has cysteine residues at positions 96, 161, 202, 356, 370, and 402 (Fig. 4-5A). A
cell lysate from an IPTG-induced culture expressing AtxA was treated with BMH,
subjected to SDS-PAGE, and probed for AtxA via Western blot (Fig. 4-4). Two bands
were detected slightly above the 98-kDa marker when the lysate was treated with
BMH (lane 6), while a single band near the 50-kDa marker was detected in an
untreated lysate (lane 2). The predicted molecular weight of AtxA is 55.6 kDa;
therefore, the approximately 100-kDa bands may represent two AtxA proteins joined
via BMH. The appearance of the doublet band indicates two separate AtxA
complexes present in the cross-linked lysate. To investigate the composition of the
protein complexes, I affinity purified AtxA-His from an atxA-null strain and subjected
the protein to BMH cross-linking. The migration pattern of cross-linked, purified AtxA-
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Figure 4-3. Specific binding of AtxA-His to AtxA-FLAG. Lysates from B. anthracis atxAnull strains (UT376) containing AtxA-His (pUTE991), AtxA-FLAG (pUTE992), or GFP-FLAG
(pUTE1013) induced with 30 µM IPTG were subjected to co-affinity purification using NTA-Ni
resin. Western blots probed with α-AtxA, α-FLAG, and α-His antibodies were performed on
soluble cell lysates (Load, lanes 1-3) and purified proteins (Eluate, lanes 4-6).
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Figure 4-4. Fixation of AtxA complexes with a cysteine-reactive cross-linking agent.
Cultures of the atxA-null strain UT376 containing pUTE658 (encoding AtxA) or pUTE991
(encoding AtxA-His) were induced with 40 µM IPTG. Cell lysates or affinity-purified AtxA-His
were treated with the cross-linking agent BMH. SDS-PAGE (4-15%) and Western blots with
AtxA-specific antibody were used to detect various forms of AtxA. EV = empty vector, L = cell
lysate, and AP = affinity-purified. Molecular weights of the protein standards are listed
(SeeBlue Plus2, Invitrogen).
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His was similar to that observed for AtxA and AtxA-His cross-linked in cell lysates
(Fig. 4-4, lanes 6-8); a doublet band migrated near the 98-kDa molecular weight
marker. I conclude that the doublet does not result from AtxA linked to another
protein. Rather, the doublet suggests at least two conformational states of the dimeric
AtxA complex.
“BMH-mediated cross-linking of AtxA proteins allowed me to test for region(s)
at the interface of AtxA multimers. I created strains harboring distinct atxA CysSer
alleles (Fig. 4-5A). Mutant AtxA proteins were expressed in the atxA-null background
and cell lysates were reacted with BMH. The presence of the dimer band in lysates
containing mutated AtxA (Fig. 4-5B) indicates that these proteins are capable of
multimerization and are cross-linked with BMH. The lysate containing AtxA C402S
differed significantly from lysates containing other AtxA mutants. The AtxA C402S
sample contained a relatively low level of cross-linked protein and a high level of the
apparent monomer. This result suggests that C402 is the major site of BMH
crosslinking, but some other Cys residue(s) can participate in cross-linking.
“To determine if the dominant BMH cross-link occurs between C402 of two
AtxA monomers, AtxA C402S-FLAG was expressed in the parent strain of B.
anthracis, which also expresses native AtxA from the atxA locus on pXO1. I reasoned
that if BMH utilizes C402 on both proteins then, after cross-linking, FLAG-reactive
protein would be detected as a monomer band (55 kDa) and not as a dimer
containing AtxA C402S-FLAG and AtxA. Following BMH cross-linking, the native AtxA
plus AtxA C402S-FLAG sample contained a high level of monomer when examined in
Western blots probed with α-FLAG antibody (Fig. 4-5C, lane 5) similar to the sample
containing only AtxA C402S (Fig. 4-5B, lane 8). In contrast, samples containing native
AtxA plus CysSer AtxA mutant proteins (C202S and C370S) or native AtxA plus
AtxA-FLAG showed high levels of cross-linked protein reacting with α-FLAG antibody
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Figure 4-5. Determination of the site of BMH cross-linking. (A) The AtxA protein, which
contains six cysteine residues, has five putative motifs: a winged helix-turn-helix (WH), a
Mga-like helix-turn-helix (HTH), two phosphotransferase regulation domains (PRD1 and
PRD2), and an Enzyme IIB-like motif (EIIB). (B) Following induction with 30 µM IPTG, cells
from cultures of atxA-null strains (UT376) containing pUTE658-derived atxA point mutants
were lysed and treated with BMH. SDS-PAGE (4-15%) and Western blots with AtxA-specific
antibody were used to detect various forms of AtxA. (C) A similar experiment was performed
using derivatives of the parent strain (UT375) expressing atxA from its native locus and
pUTE992-derived FLAG-tagged versions of AtxA or the AtxA point mutants. Westerns were
probed with α-FLAG and α-AtxA antibodies. EV = empty vector. Molecular weights of the
protein standards are as indicated (SeeBlue Plus2, Invitrogen).
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(Fig. 4-5C, lanes 2-4). Further, when the same samples were probed with α-AtxA
antibody, dimer bands representing cross-linked AtxA (tagged and native) were
present in all samples (lanes 6-10). Dimer bands detected in the AtxA C402S-FLAG
plus AtxA sample probed with α-AtxA (lane 10) likely represent native AtxA because
dimer bands were not detected when the same sample was probed with α-FLAG
antibody (lane 5). The relatively low level of cross-linked protein in the sample
containing only native AtxA (lane 6) and the sample containing native AtxA plus AtxA
C402S-FLAG (lane 10) reflect low level AtxA expression from the native atxA locus.
Induction of the tagged proteins (lanes 2-5 and 7-10) resulted in approximately 8.5fold more tagged protein compared to native AtxA (Untreated lanes and data not
shown). These results indicate that the major BMH cross-linked species is formed
using C402 on two AtxA monomers.
“To verify that AtxA C402S can form a complex with AtxA despite being
defective for BMH cross-linking, I performed a co-affinity purification experiment using
AtxA C402S-FLAG mixed with AtxA-His. After eluting protein from NTA-Ni resin, AtxA
C402S-FLAG was present in the sample with AtxA-His, indicating that AtxA C402S
has normal multimerization properties (Fig. 4-6). Taken together, these data
demonstrate that BMH utilizes C402 to cross-link two AtxA proteins and suggests that
the carboxy-terminus of AtxA is involved in oligomerization.
“Assessment of the carboxy-terminal 91-amino acid sequence of AtxA using
the Conserved Domains Database (136) and Protein Homology/Analogy Recognition
Engine (Phyre, (137)), predicted that this region of AtxA is similar to an EIIB motif of
the PTS, as depicted in Figure 4-5A. EIIB domains typically function enzymatically to
phosphorylate carbohydrates after the sugars cross the cell membrane via an EIIC
domain or protein. I performed cross-linking experiments using full length AtxA, AtxA1385

(deletion of the EIIB-like motif), and AtxA385-475 (only the EIIB-like motif) to
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Figure 4-6. AtxA C402S does not have a multimerization defect. Lysates from the
B. anthracis atxA-null strain UT376 expressing AtxA-His (pUTE991), GFP-FLAG
(pUTE1013), AtxA-FLAG (pUTE992), or AtxA C402S-FLAG (pUTE992 C402S) were
subjected to co-affinity purification using NTA-Ni resin. Samples were treated as
described in Fig. 4-3.
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determine if the EIIB-like region of AtxA is involved in AtxA oligomerization. Cell
lysates containing full-length and truncated FLAG-tagged proteins synthesized in
parent and atxA-null backgrounds were subjected to BMH cross-linking. Bands
corresponding to 56-kD, 40-kD, and 11-kD monomers of AtxA-FLAG, AtxA1-385-FLAG
and AtxA385-475-FLAG, respectively, were observed in untreated lysates probed with αFLAG antibody (Fig. 4-7 lanes 2-4 and 6-8). The BMH-treated samples displayed the
typical dimer bands (100 kDa) for AtxA-FLAG (lanes 10 and 14). The migration of
AtxA1-385-FLAG was not altered after cross-linking; only a 40-kDa band was present
(lanes 11 and 15). This result is consistent with the requirement of C402 for crosslinking. The several FLAG-reactive bands present in lanes 12 and 16 represent
multiple protein complexes containing AtxA385-475-FLAG and unidentified proteins. The
large α-FLAG-reactive cross-linking products do not represent AtxA cross-linked to
AtxA385-475-FLAG because the banding patterns of AtxA385-475-FLAG in the parent (lane
12) and atxA-null strain (lane 16) were identical. These data indicate that the EIIB-like
region of AtxA is involved in AtxA oligomerization and suggest that the EIIB-like
domain in the absence of other regions of the AtxA protein displays less specificity for
AtxA, interacting with several other proteins in cell lysates. It is notable that the
truncated AtxA proteins do not exhibit AtxA activity. B. anthracis UT376 mutants
producing AtxA1-385, AtxA1-385-FLAG, AtxA385-475, or AtxA385-475-FLAG show no
expression of the Plef-lacZ fusion (data not shown).” (102)

4.2.4 Relationship between CO2/bicarbonate, AtxA multimerization and function
“AtxA-dependent transcription of lef and other genes is enhanced during
growth in buffered media in 5% CO2, relative to growth in air (46, 49, 50, 71). To
address relationships between the CO2/bicarbonate signal, the oligomeric state of
AtxA, and AtxA function in vivo, I compared AtxA multimerization and activity using
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Figure 4-7. Multimerization of AtxA385-475. Cell lysates of parent (UT375) and atxAnull strains (UT376) containing AtxA-FLAG (pUTE992), AtxA1-385-FLAG (pUTE1019FLAG), and AtxA385-475-FLAG (pUTE1022-FLAG) induced using 30 - 50 µM IPTG
were treated with the cross-linking agent BMH. SDS-PAGE (4-20%) and Western
blots with FLAG-specific antibody were used to detect various forms of AtxA. EV =
empty vector. Molecular weights of the protein standards are listed (SeeBlue Plus2,
Invitrogen).
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cells cultured in CA medium with or without CO2/bicarbonate. Growth rates and IPTGinduced AtxA levels were similar for B. anthracis UT376 (pUTE658) cultures grown
with or without added CO2/bicarbonate (data not shown). For each culture, AtxA
function was assessed as β-galactosidase activity resulting from expression of the
Plef-lacZ reporter gene, and cell lysates were subjected to BMH-mediated crosslinking to determine the levels of AtxA dimer. A representative experiment is shown in
Figure 4-8. The AtxA dimer/monomer ratio was approximately 2-fold greater in cells
cultured with elevated CO2/bicarbonate. The increased dimer level correlated with
increased AtxA activity. The affect of the CO2/bicarbonate signal on the AtxA
dimer/monomer ratio and AtxA activity was consistent in multiple experiments. These
results show that the CO2/bicarbonate signal shifts the dimer/monomer equilibrium of
AtxA toward the dimeric state and this shift is associated with enhanced protein
function.”(102)
4.3 Discussion
“I have determined that AtxA forms a multimeric protein complex independent
of other proteins, and that the level of homodimeric AtxA is increased relative to
monomeric AtxA in cells cultured in conditions conducive for function. My experiments
employing the BMH cross-linking reagent allow me to discern features of the AtxA
multimer. BMH is specific for reduced, solvent-accessible cysteines located within 13
Å. I determined that C402 is the major site of cross-linking between two AtxA proteins,
suggesting that C402 is likely surface exposed and in proximity to the corresponding
amino acid in an AtxA dimer. Since BMH cross-linking requires reduced cysteines, the
C402 residues of associated AtxA proteins do not form a disulfide bond. Moreover, a
C402S mutant forms multimers that are indistinguishable from those formed by the
native protein. My data indicate that C402 is located in a region of AtxA that forms
protein-protein contacts, yet C402 is not required for the protein-protein interactions.
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Figure 4-8. The CO2/bicarbonate effect on AtxA multimerization and activity.
UT376 (pUTE658), an atxA-null strain harboring the native atxA gene driven by an
IPTG-inducible promoter and the Plef-lacZ transcriptional fusion (as a reporter for
AtxA activity) was cultured in CA in air and in CACO3 in a 5% CO2 atmosphere. Cells
were collected two hours after induction with IPTG. (A) SDS-PAGE (4-15%) and
Western blots with AtxA-specific antibody were used to detect various forms of AtxA.
EV = empty vector (pUTE657), L = cell lysate, U = untreated samples, B = BMH
treated samples. (B) Intensities of bands corresponding to the AtxA dimer and
monomer were measured using ImageJ. Dimer/monomer ratios are shown as gray
bars. β-galactosidase activities, resulting from expression of the Plef-lacZ reporter,
are shown as black bars.
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“The Protein Homology/Analogy Recognition Engine “Phyre” (137) is a
homology-based, fold-recognition tool that provides three-dimensional structure
predictions based on sequence similarity to proteins with known structures. Phyre
reveals similarity between AtxA385-475, containing C402, and EIIB motifs of PTS
proteins, leading me to propose a function for the carboxy-terminus of AtxA. As part
of the PTS, EIIB proteins are the penultimate proteins in the phosphotransfer from
phosphoenol-pyruvate (PEP) to imported carbohydrates (73).

Within the PTS,

Enzyme II (EII) complexes, consisting of EIIA, EIIB, and EIIC(D), recognize and
transport specific carbohydrates.

After EI-dependent phosphorylation of HPr, the

phosphate is transferred EIIA. EIIA~P phosphorylates EIIB at a conserved cysteine
residue within the P-loop, a flexible loop between β-strand 1 and α-helix 1 (138). The
phosphocysteine of EIIB transfers its phosphate to carbohydrate molecules crossing
the cell membrane via the EIIC(D) complex. The carboxy-terminus of AtxA is similar
to GatB, an E. coli protein that is a member of the glucitol/galacitol family of EIIB
proteins (139). NMR studies of GatB with its cognate EIIA (GatA) reveal regions of
GatB – GatA interaction. It is thought that the GatB-GatA interface, which includes
the P-loop, is also recognized by the corresponding EIIC protein, GatC (140).
“Interaction of GatB with two different proteins suggests involvement of EIIBlike motifs in protein-protein binding. In experiments when AtxA385-475-FLAG is
induced in an atxA-null strain or the parent strain containing AtxA, I detect four
prominent α-FLAG-reactive products in cross-linked cell lysates. In contrast, when
full-length AtxA-FLAG is induced in either strain, cross-linked lysates contain only one
α-FLAG-reactive product, which corresponds to an AtxA-AtxA dimer. The presence
of multiple cross-linked products in the AtxA385-475 sample suggests that the EIIB-like
motif in the absence of other AtxA domains loses some specificity for protein-protein
interactions. These data lead me to propose that the EIIB-like motif is involved in the
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AtxA-AtxA interaction, yet one or more motifs within residues 1-385 of AtxA are
required to confer specificity to the AtxA-AtxA interaction and to exclude interactions
of the AtxA EIIB-like domain with other proteins.
“The presence of an EllB-like motif adjacent to PRDs is not unique to AtxA
(see Fig. 1-2). EIIB-like domains are found in certain other regulators, including the
transcriptional activators LicR, MtlR, CelR, ManR and LevR (73, 82, 141). Yet, unlike
AtxA, these other regulators also contain EIIA-like motifs and the regulators control a
small number of genes encoding proteins associated with use of a specific
carbohydrate or group of carbohydrates. For example, in Streptococcus mutans CelR
regulates the production of proteins required for cellobiose catabolism (142), and
MtlR induces expression of the mtl operon when Bacillus subitilis is in the presence of
mannitol (84, 143). In contrast, AtxA is a virulence gene regulator that affects
transcription of multiple genes on the chromosome and virulence plasmids within B.
anthracis, none of which are known to be associated with catabolism (57).
“Interestingly, a cysteine residue within the EIIB-like motif in the MtlR protein
of B. subtilis was recently shown to be phosphorylated (82). MtlR activity decreases
when P~EIIAMtl phosphorylates MtlR at C419, the conserved cysteine within the Ploop of the EIIB-like motif. In the Phyre-produced model of the EIIB-like motif of AtxA,
C402 is located in the P-loop, but the residue is not at the position typically observed
for the conserved phosphocysteine in EIIB proteins of the PTS or for the EIIB-like
motif in MtlR and LicT. Moreover, current data do not support phosphorylation of AtxA
at this site. Phosphorylated C402 would have prevented cross-linking by BMH in my
experiments. Also, Tsvetanova et al. (59), reported that phosphorylation of AtxA
occurs only within the PRDs at residues H199 and H379.
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PO4-labelled AtxA was

immunoprecipitated from B. anthracis cell lysates, but no radio-labelled AtxA was
evident in a H199A / H379A mutant.
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“Phosphorylation of AtxA may impact the multimeric state of the protein.
Phosphorylation can stabilize or disrupt dimerization of the PRD-containing
antiterminator proteins LicT and BglG (79, 80, 128, 134).

Dimer contacts within the

PRDs of LicT are confined to α-helices 2, 3, and 5 in each PRD, and the helices are
arranged in an anti-parallel orientation (135). Considering reports concerning LicT
and BglG, it is possible that the AtxA PRDs are involved in multimerization. The
Phyre-predicted structure of the PRDs of AtxA positions C202 in α-2 of PRD1, C356
in α-4 of PRD2, and C370 in α-5 of PRD2, yet in my studies, C202, C356, and C370
were not required for cross-linking of AtxA proteins by BMH. It is possible that these
cysteine residues are in regions that function in multimerization.

However, the

sulfhydryl groups are inaccessible to BMH because they are buried in the interior of
AtxA, oxidized into a disulfide bond, or are greater than 13 Å from another cysteine.
More work needs to be performed to determine the protein-protein contacts existing
throughout the AtxA protein and to assess potential effects of phosphorylation on
multimerization of AtxA (See Ch. 5).
“My findings show for the first time a link between AtxA multimerization,
function and an important signal for virulence gene synthesis by B. anthracis.
Increased synthesis of PDGA capsule and the anthrax toxin proteins during culture of
B. anthracis in the presence of elevated CO2/bicarbonate was first reported more than
sixty years ago. Yet, the mechanism by which this physiologically relevant signal
affects expression of these critical virulence factors has remained largely unknown. In
work presented here, I have determined that B. anthracis cultures grown in elevated
CO2/bicarbonate contain higher levels of the AtxA dimer than cultures grown in air.
Conditions that enhance dimerization also promote AtxA target gene expression. The
positive correlation between CO2/bicarbonate level, the presence of AtxA dimers, and
AtxA activity links the signal to AtxA structure and function.
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“Many questions remain regarding the mechanism by which CO2/bicarbonate
affects AtxA function. Genetic and biochemical searches have not revealed any
cellular factors that might bridge the link between the CO2/bicarbonate signal and the
AtxA protein. I speculate that AtxA may bind to bicarbonate or CO2 directly. To my
knowledge, only one bacterial regulatory protein has been shown to require
bicarbonate to stably interact with target promoter sequences. RegA, an AraC/XylSlike regulator found in Citrobacter rodentium, binds to bicarbonate via an aminoterminal motif (144). According to the model proposed by Yang et al. (145), the
binding of bicarbonate to RegA facilitates interaction of its carboxy-terminal DNA
binding motif with target sequences. AtxA does not bear apparent sequence
homology to RegA, although a binding pocket may not be obvious. Multiple
bicarbonate-binding proteins, with varying bicarbonate binding sites and diverse
functions have been reported, including proteins associated with photosynthesis and
menaquione biosynthesis (146, 147). Direct association of bicarbonate with AtxA
multimers is currently under investigation.
“Finally, my experiments were designed to detect stable protein-protein
complexes. I do not exclude the possibility of other AtxA-protein interactions.
Considering that specific DNA-binding activity has not been demonstrated for purified
AtxA protein, it is possible that an additional protein interacts with AtxA to allow
specific DNA-binding. Moreover, a specific multimeric and/or phosphorylated form of
AtxA may be required to observe this activity. Although it has been suggested that
AtxA phosphorylation occurs via the HPr enzyme of the PTS, the kinase has not been
identified experimentally. It is likely that the enzyme responsible for phosphorylation
of AtxA makes transient protein-protein contacts and thus would not be identified by
the approaches used here.
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“My working model is that formation of an AtxA homo-dimer is required for
virulence gene activation. Future studies will focus on potential relationships between
phosphorylation, multimerization, and function of AtxA.” (102)
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Chapter V
The B. anthracis phosphoenolpyruvate:sugar phosphotransferase
system (PTS) regulates expression, not function, of AtxA, the virulence
gene regulator.
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5.1 Introduction
The phosphoenolpyruvate: sugar dependent phosphotransferase system (PTS)
serves as a central processing circuit, allowing bacteria to adapt to changing conditions in
the local environment (73). The PTS directs carbon catabolite repression (CCR) and carbon
catabolite activation (CCA) which affect genes involved in metabolism and bacterial
pathogenesis (74, 148). Moreover, the PTS phosphorylates proteins as the primary
mechanism to modify metabolism.
CCA and CCR and PTS-dependent phosphorylation are intersecting pathways that
converge with the protein HPr.

In Bacillus subtilis, HPr, the second of the two general

enzymes in the PTS (EI and HPr), is phosphorylated by two proteins ((74), see Fig. 1-3).
H15 of HPr (P~His-HPr) is phosphorylated by EI following catalysis of phosphoenolpyruvate
(PEP) to pyruvate. To generate P-Ser-HPr, S46 of HPr is phosphorylated by HprK/P in an
ATP-dependent fashion when cellular levels of fructose-1,6-bisphosphate (FBP) are high (> 5
mM). Some carbohydrates promote phosphorylation on H15 and S46 in the same molecule
of HPr (HPr-P2). A bacterium’s carbon source dictates the proportion of P~His-HPr, P-SerHPr, and HPr-P2 in the cell (149). P~His-HPr phosphorylates several different types of
proteins, whereas P-Ser-HPr specifically interacts with CcpA to induce CCA and CCR.
P~His-HPr is responsible for phosphorylating EIIA (73), GlpK (150, 151), and PRDcontaining antiterminators and activators (73).

The phosphorylated proteins promote

catabolism of a specific sugar (EIIA and GlpK) or increase the transcription of genes needed
for sugar catabolism (PRD-containing proteins). P~His-HPr phosphorylates two histidines
within PRD2 of LicT, a B. subtilis antiterminator protein controlling genes involved in the
metabolism of β-glucosides (77, 152, 153). Once phosphorylated, LicT homodimerizes and
prevents transcriptional termination of the lic operon (79).
P-Ser-HPr forms a heterotetramer with CcpA, the master regulator of CCA and CCR
within low G+C Gram-positive bacteria (74). The complex binds to promoter elements (cre
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sites) to repress (CCR) or activate (CCA) transcription (154). In B. subtilis, ~10% of the
genome is regulated via CcpA/P-Ser-HPr (155). Glucose is one of a few carbohydrates that
increase the intracellular concentration of FBP leading to increased HprK/P phosphorylation
of HPr (149). The CcpA regulon includes genes associated with pathogenesis of Listeria
monocytogenes, Streptococcus pyogenes, and Bacillus anthracis (66, 76, 156).
Recent discoveries implicate P~His-HPr and P-Ser-HPr in the regulation of virulence
in B. anthracis, the causative agent of anthrax disease.

Transcriptional activation of

virulence genes occurs via AtxA, a PRD-containing protein encoded on the large plasmid
pXO1 (46, 47). P~His-HPr of the PTS has been suggested to phosphorylate a histidine
within the PRDs of AtxA (59, 157).

Moreover, the CcpA/P-Ser-HPr complex indirectly

promotes transcription of atxA (66).
P~His-HPr may phosphorylate AtxA on H199 and indirectly provide the phosphate
needed for another protein to phosphorylate H379. According to the current model for AtxA
function, phosphorylation of AtxA at H199 increases AtxA activity whereas at H379 it reduces
the function of the protein (59). Using point mutations mimicking the phosphorylated and
non-phosphorylated states (HD and HA, respectively), Tsvetanova et al. (59) assessed
the function of AtxA point mutations using a pagA-lacZ reporter fusion in the heterologous
host B. subtilis.

AtxA H199D had the highest activity though it produced only 1.3 times the

activity of AtxA, whereas expression of pagA-lacZ via AtxA H199A was reduced sixfold.
AtxA H379D displayed the lowest function as it induced little or no expression of the reporter
fusion. In contrast, AtxA H379A had similar activity as the wild type protein. To confirm the
data from the B. subtilis reporter, the authors detected PA protein in culture supernates from
B. anthracis strains expressing the mutated proteins. Significantly, in vivo
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P-labeled AtxA

was immunoprecipitated from B. anthracis cell lysates; however, the bacteria were cultured
in a medium that does not promote high levels of AtxA activity. AtxA H199A and AtxA
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H379A were phosphorylated as well; however, AtxA H199A/H379A, the double mutant, was
not labeled. These data indicated that AtxA was phosphorylated at H199 and H379.
There is some evidence that the PTS represses AtxA function via phosphorylation of
H199 and/or H379 (59). A B. subtilis mutant lacking HPr and EI via a deletion in ptsHI
produces twofold higher AtxA activity than the B. subtilis parent strain. B. subtilis cultured in
medium supplemented with glucose was delayed in pagA-lacZ expression.

These data

supported a model that AtxA is phosphorylated via a mechanism involving P~His-HPr (59,
157).

In contrast, when B. anthracis, the native host of AtxA, was cultured in medium

containing glucose, more toxin gene and atxA expression were detected than in medium
lacking the carbohydrate. The observation that atxA and toxin gene expression increase in
glucose-containing medium indicated that atxA was subject to CCA. The result from B.
subtilis, the heterologous host, indicated that atxA was repressed in glucose-containing
medium; however, atxA gene expression was stimulated by glucose in B. anthracis (66).
The glucose-effect on atxA expression in B. anthracis is mediated by CcpA. After
determining that AtxA protein function was unaffected by glucose, Chiang et al. (66)
demonstrated that a B. anthracis ΔccpA mutant reduced the amount of atxA and toxin gene
transcripts similar to cultures without glucose. However, there is not a cre site near the atxA
promoter and purified CcpA was not able to bind to the atxA promoter; therefore, the
mechanism of CcpA-dependent regulation of atxA has not been elucidated. It is proposed
that CcpA and P-Ser-HPr cooperatively activate the atxA promoter in an indirect manner
(66); however, there is no conclusive link between HPr and atxA transcription.
Since CcpA/P-Ser-HPr regulates transcription of specific genes and P~His-HPr may
phosphorylate PRD-containing proteins, I hypothesize that the PTS regulates B. anthracis
virulence in two ways. CcpA/P-Ser-HPr may activate transcription of atxA while P~His-HPr
phosphorylates AtxA. In work presented in this chapter, I present experiments which provide
support for HPr function in atxA transcription; however, my data show that the PTS does not
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affect AtxA protein function. Because the kinase of AtxA is unknown, I investigated the
multimeric properties of phosphomimetic versions of AtxA to determine if the mutant proteins
follow the model of PRD-containing proteins.

5.2 Results
5.2.1 EI and HPr do not phosphorylate AtxA in vitro.
Previously, it was shown that the PRDs within AtxA were phosphorylated in vivo
potentially via the PTS (59).

As shown with LicT and MtlR (84, 153), PRD-containing

proteins can be phosphorylated in vitro when combined with EI, HPr, and
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P-PEP. Given

the presence of PRDs within AtxA, I hypothesized that HPr phosphorylates AtxA.
To address this question, I attempted an in vitro phosphotransferase experiment.
AtxA containing a carboxy-terminal hexa-histidine tag (AtxA-His) was purified from B.
anthracis to yield highly purified, soluble protein (see Fig. 4-2B).

Expression of hexa-

histidine-tagged versions of HPr and EI was induced via the IPTG-inducible Phs in B.
anthracis, and the proteins were purified via NTA-Ni affinity chromatography. EI-His, HPrHis, and AtxA-His were incubated with
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P-PEP and subjected to SDS-PAGE. A phosphor-

image of the experiment displayed phosphorylated EI-His and HPr-His (Fig. 5-1A, lanes 1, 4,
5, and 7). An unidentified protein was also present in lanes 1, 4, 5, and 7. I presume that
the protein was a fragment of EI. HPr-His and AtxA-His were not phosphorylated when they
were alone or incubated together (lanes 2, 3, and 6).
phosphorylated by EI-His and HPr-His (lane 7).

Moreover, AtxA-His was not

All three proteins were detected via

immunoblot analysis using α-His antibody (Fig. 5-1B). The lack of AtxA phosphorylation was
surprising, because HPr has been demonstrated to phosphorylate several PRD-proteins
during in vitro reactions (82, 84, 153, 158–160). The results suggest that EI and HPr do not
transfer phosphate directly to AtxA.
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Figure 5-1. Phosphotransferase assay does not produce phosphorylated AtxA. HexaHis tagged EI, HPr, and AtxA were induced in B. anthracis and purified via nickel-affinity
purification. A.32P-PEP was mixed with the proteins and incubated at 37° C for 30 min.
Samples were separated on 10% poly-acrylamide-SDS gels, dried, and exposed to a
phosphor-imaging screen. B. The proteins also were subjected to SDS-PAGE and probed
with α-His antibody. Proteins present in each lane are indicated by the table.
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5.2.2 The PTS affects transcription of atxA
To substantiate the results of the in vitro phosphotransferase assay and further
investigate the role of EI and HPr on AtxA function, I constructed a markerless mutation of
ptsHI in B. anthracis. When a B. subtilis ΔptsHI mutant was tested for AtxA activity, the
mutant displayed higher expression of an AtxA-dependent target (pagA-lacZ) than the parent
strain (59). Given the difference between B. subtilis and B. anthracis in the effect of glucose
on toxin gene expression, it is necessary to determine in B. anthracis the relationship
between AtxA and the PTS.
The genes encoding HPr and EI were deleted from the chromosome of two strains of
B. anthracis: a parent strain (ANR-1) and an isogenic strain (UT375) that includes lacZ
integrated at the native lef locus (Plef-lacZ). Plef-lacZ provides a quantitative reporter of
AtxA function in vivo. The lef gene encodes for the Lethal Factor (LF), one of the anthrax
toxin proteins, and transcription of the gene is highly dependent upon AtxA (46, 49). The
ANR-1 ptsHI mutant (UT405) and the UT375 ptsHI mutant (UT408) displayed a slight
reduction in replication rate in toxin-inducing medium (CACO3) but had no growth defect in
rich medium (LB or BHI media) (data not shown).
To assess atxA transcription and AtxA activity, low-copy plasmids carrying
transcriptional reporters, PatxA-lacZ or Plef-lacZ, were inserted into UT405.

The ptsHI

mutant displayed little lacZ activity from either promoter fusion when streaked on a CACO3
plate containing X-gal (Fig. 5-2A).

In contrast, the parent strain containing the reporter

fusions displayed β-galactosidase activity indicating the atxA and lef promoters were active.
These data suggest that ptsHI affects atxA transcription.
The ptsHI mutation was complemented by inducing expression (Phs) of His-tagged
alleles of ptsH or ptsI or the native version of the ptsHI bicistron. The UT375-derived ptsHInull mutant (UT408) containing the complementation vectors was cultured in toxin-inducing
conditions. Induction of HPr and EI began during early exponential phase of growth (2 h,
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Figure 5-2. ptsHI mutation affects expression of atxA in B. anthracis.
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Figure 5-2. ptsHI mutation affects expression of atxA in B. anthracis. A markerless
mutation of ptsHI was constructed in the ANR-1 strain of B. anthracis producing UT405. A.
Plasmid-borne transcriptional reporters of the promoters for atxA and a toxin gene (PatxAlacZ and Plef-lacZ, respectively) were transformed into the mutant and parent strain. The
strains were streaked onto CACO3 plates containing X-gal and incubated at 37° C with 5%
CO2.
To create UT408, the mutation was made in the ANR-1 derived strain UT375 which
contains an integrated lacZ gene in the lef locus. Plasmids containing ptsH (H), ptsI (I), or
ptsHI (HI) controlled by an IPTG-inducible promoter (Phs) or the empty vector (EV) were
introduced into UT408 and its parent strain, UT375. B. The strains were cultured in CACO 3
with added glycerol. After induction of ptsH, ptsI, or ptsHI using 250 µM IPTG (2 h, OD600 =
0.202 – 0.302), soluble cell lysates were created at the transition to stationary phase (4 h,
OD600 = 0.93 – 1.43) and subjected to SDS-PAGE and Western blot analysis using α-AtxA
and α-RNA Polymerase β subunit. C. The β-galactosidase activity of B. anthracis mutants
harboring the Plef-lacZ reporter (UT375 and UT408) and IPTG-inducible ptsH, ptsI, or ptsHI
was determined as described previously (130). These data are representative of three
experiments.
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OD600 = 0.202 – 0.302) and samples for AtxA westerns and β-galactosidase assays were
collected at the transition to stationary phase (4 h, OD600 = 0.93 – 1.43). Only the dual
expression of HPr and EI restored AtxA protein levels and Plef-lacZ activity (Fig. 5-2B, lane
5, and 5-2C).

AtxA was not detected on the Western blot in the ptsHI mutant strain

containing the empty vector or expressing HPr-His or EI-His alone (lanes 3 and 4). These
data support the results from the plate assays (Fig. 5-2A) and indicate that mutation of ptsHI
abrogates atxA transcription which leads to decreased activation of lef. It is likely that the
mechanism by which ptsHI affects atxA involves CcpA, which was shown previously to
regulate atxA (66).

5.2.3 AtxA function is independent of ptsHI
It was surprising that mutation of ptsHI leads to decreased amounts of atxA transcript,
because in most instances, PRD-containing proteins are regulated post-translationally via
HPr phosphorylation, not by transcriptional control via CcpA/P-Ser-HPr (73, 82).
exception is a LevR-like protein in Lactobacillus casei (161).

One

LevR, characterized in B.

subtilis, is a PRD-harboring protein that regulates the fructose-specific PTS (83). In L. casei,
the activity of the LevR-like protein is regulated via phosphorylation by P~His-HPr, and
expression of the LevR-like protein is regulated by CcpA/P-Ser-HPr (161). To determine if
the PTS affects AtxA protein function in addition to promoter activity, I investigated if AtxA
activity was altered in the ΔptsHI mutant.
The PTS can both positively and negatively regulate PRD-containing proteins (73);
therefore, it may decrease or increase AtxA activity. If the PTS induces AtxA function, then
the protein’s activity may be diminished when the mutant strain is cultured in toxin-inducing
conditions (CACO3).

On the other hand, if the PTS decreases AtxA activity, AtxA may

display a hyper-active phenotype in the ptsHI mutant cultured in a medium that does not
produce optimal levels of toxin (LB-air).
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To produce AtxA and measure the amount of AtxA activity, I transformed the UT375
ΔptsHI strain (UT408) with the IPTG-inducible Phs-atxA expression vector (pUTE658). The
strain was cultured alongside the parent strain (UT375) and a UT375-derived atxA-null strain
(UT376) in CACO3 or LB-air. These three strains contain the Plef-lacZ reporter integrated at
the lef locus.

After induction with IPTG during early exponential phase, samples were

collected at the transition to stationary phase for Western blots and Plef-lacZ activity assays.
AtxA was present in CACO3 cultures of the parent strain containing the empty vector and the
mutant strains inducing Phs-atxA (Fig. 5-3A, lanes 1, 3, and 5). All samples containing
detectable amounts of AtxA also exhibited equivalent β-galactosidase activities (Fig. 5-3C).
These data indicated that AtxA function was not activated by ptsHI. When culturing in LB-air,
AtxA protein was detected only in strains containing Phs-atxA and induced with IPTG (Fig. 53B, lanes 8 and 10). The activities of AtxA were over 2-logs lower in strains containing AtxA
than the same strains cultured in CACO3 (Fig. 5-3D, compare to Fig. 5-3B). There was little
difference between the Plef-lacZ activities in the ΔatxA – Phs-atxA and ΔptsHI – Phs-atxA
strains. These data suggested that EI and HPr and the proteins that are phosphorylated by
EI and HPr do not negatively impact AtxA protein function.
When data from the in vitro and in vivo assays are analyzed collectively, I conclude
that EI and HPr, and by extension, the entire PTS, affect virulence gene regulation via the
control of atxA gene expression and the system has no control over AtxA protein function.

5.2.4 Effects of phosphomimetic mutations on AtxA multimerization and function
Although the PTS does not phosphorylate AtxA, data suggest that AtxA is
phosphorylated in vivo (59). Using HA and HD point mutations within AtxA, the authors
conducted experiments suggesting that phosphorylation of H199 promotes AtxA activity and
H379 phosphorylation decreases AtxA activity.

Alanine substitutions mimic the non-

phosphorylated state of a histidine, while HD mutations are similar to a phosphohistidine. It
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Figure 5-3. Expression of AtxA in B. anthracis PTS mutants. UT375-derived ptsHI and
atxA mutant strains (UT408 and UT376, respectively) containing a plasmid-encoded IPTGinducible atxA (Phs-atxA) or an empty vector (EV) were cultured in conditions optimal
(CACO3, see A. and C.) or suboptimal (LB-air, see B. and D.) for toxin gene expression.
AtxA production was induced during early exponential phase (2 h) and samples were
collected for immunoblots or β-galactosidase assays (4 h). Representative data are shown.
A. and B. Soluble cell lysates migrated through 10% poly-acrylamide SDS gels and were
probed with α-AtxA antibody. RNA Polymerase β subunit or a cross-reactive band are
shown as loading controls. C. and D. The β-galactosidase activity of each strain was
determined as described previously (130).
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is unknown if phosphorylation affects the amount of AtxA multimer, which is proposed to be
needed for AtxA to be active (see Chapter 4).
To determine the oligomeric state of AtxA phosphomimetic mutant proteins, I created
AtxA H199 and H379 mutations in the Phs-atxA expression vector (pUTE658) and expressed
the proteins in UT376, an atxA-null mutant harboring a transcriptional fusion, Plef-lacZ.
While culturing in toxin inducing medium, cells were induced with IPTG during early
exponential phase (T2), and samples were collected at the transition to stationary phase (T4)
to assess the activity and multimeric state of each mutant protein (Fig. 5-4).

As seen

previously (59), AtxA H199D and AtxA H379A had activity similar to the parent strain in a
representative experiment, AtxA H199A had 3-fold less activity, and the activity of AtxA
H379D is slightly greater than the empty vector control (Fig. 5-4A).
To detect multimerization of the mutant proteins, I performed co-affinity purification
(co-AP) and bis(maleimido) hexane (BMH) cross-linking assays.

The co-AP experiment

determines if a FLAG-tagged protein interacts with an affinity-purified His-tagged protein. The
Load samples (Fig. 5-4B, lanes 1-6) display the proteins induced in each pool of cell lysates.
FLAG-tagged proteins which interact with AtxA-His during the NTA-Ni purification were
detected via α-FLAG immunoblots of the eluate samples (Fig. 5-4B, lanes 7-12, middle
panel). AtxA-FLAG stably interacts with AtxA-His as previously demonstrated (Fig. 5-4B lane
8, and Fig. 4-3). AtxA H199A-FLAG, AtxA H199D-FLAG, and AtxA H379A-FLAG co-affinity
purify with AtxA-His. In contrast, AtxA H379D-FLAG was not visible after elution of the
proteins from the NTA-Ni resin (Fig. 5-4B, lane 12).
In the BMH cross-linking experiment, BMH reacts specifically with C402 of AtxA to
covalently link two AtxA proteins within an AtxA multimer (Fig. 4-5).

Cell lysates were

created from strains inducing the untagged AtxA mutant proteins. After treatment with BMH,
the dominant form of AtxA detected via Western blot after SDS-PAGE was the homodimer at
~100 kDa (Fig. 5-4C, lane 2).

Bands with similar mobilities were visible in lanes 3-5,
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Figure 5-4. Phosphomimetic mutations affect AtxA activity and multimerization.

90

Figure 5-4. Phosphomimetic mutations affect AtxA activity and multimerization. B.
anthracis atxA-null strains (UT376) containing pUTE658 (encoding AtxA or mutations in
H199 or H379) were induced with 10-40 µM IPTG while culturing in CACO3 and samples
were collected for AtxA activity and multimerization assays. A. Activity of Plef-lacZ was
determined via β-galactosidase assay as described previously (130). B. Lysates from UT376
containing AtxA-His (pUTE991), AtxA-FLAG (pUTE992) with H199 or H379 mutations, or
GFP-FLAG (pUTE1013) induced with 40-50 µM IPTG were subjected to co-affinity
purification using NTA-Ni resin. Western blots probed with α-AtxA, α-FLAG, and α-His
antibodies were performed on soluble cell lysates (Load, lanes 1-6) and purified proteins
(Eluate, lanes 7-12). C. Cultures of UT376 containing pUTE658 (encoding AtxA or
mutations in H199 or H379) were induced with 40 µM IPTG. Cell lysates were treated with
the cross-linking agent BMH. SDS-PAGE (4-15%) and Western blots with AtxA-specific
antibody were used to detect various forms of AtxA. EV = empty vector. Molecular weights of
the protein standards are listed (SeeBlue Plus2, Invitrogen).
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indicating that AtxA H199A, AtxA H199D, and AtxA H379A form a normal AtxA multimer.
Conversely, the major band for AtxA H379D was at ~50 kDa, the monomer size of AtxA. As
seen for the co-AP experiment, AtxA H379D does not appear to form a multimer. These
data indicate that H379D mutation destabilizes the AtxA multimer.

From these data, I

deduce that phosphorylation of H379 decreases AtxA activity via decreased affinity for AtxAAtxA binding.

5.3 Discussion
AtxA, the master regulator of virulence of B. anthracis, may be controlled via two
mechanisms involving HPr. Previous reports suggested that CcpA/P-Ser-HPr affects atxA
transcription and that AtxA is phosphorylated in a P~His-HPr-dependent manner (59, 66,
157). In the work presented herein, data from biochemical and genetic experiments suggest
that the PTS influences atxA transcription; however, PTS-mediated phosphorylation of AtxA
was not detected.
An in vitro phosphotransferase assay provides evidence of protein phosphorylation
via EI and HPr. In the phosphotransfer experiment, EI utilizes

32

P-PEP as a substrate to

phosphorylate HPr at H15. P~His-HPr donates its phosphate to the PRD-containing protein
in the reaction. Phosphotransferase assays have demonstrated phosphorylation of several
PRD-containing proteins including the B. subtilis proteins SacT (158), LicT (153), LevR (160),
GlcT (159), and MtlR (82). I expressed and purified amino-terminal His-tagged EI and HPr
from B. anthracis which display 74% and 73% identity, respectively, to their B. subtilis
counterparts. AtxA was not phosphorylated in the assay whether it was incubated with EI or
HPr alone or with both proteins.
Since AtxA was not phosphorylated in the experiment, it is necessary to ensure the
purified proteins (EI, HPr, and AtxA) were functional. EI is a large protein (570 amino acids,
62.9 kDa) which contains two functional domains. The amino terminus contains the site of

92

phosphorylation when the carboxy terminus catalyzes the conversion of PEP to pyruvate;
therefore, both of the domains must be active if the protein is phosphorylated. HPr contains
only 87 amino acids and is 9.2 kDa (73). P~His-HPr donates its phosphate to many proteins
including sugar-specific EIIAs (up to 15 in a single cell), glycogen phosphorylase, and PRDcontaining proteins (73). The same narrow region of HPr is used to interact with EI, EIIAs, or
glycogen phosphorylase (162, 163). Thus, like EI, if HPr is phosphorylated it is presumed to
be functional. Purified AtxA has been shown to bind DNA (Fig. 3-4) and form multimers in
solution (Fig. 4-2), thus it is likely that it is folded correctly. These data suggest that the
proteins are functional; however, a protein known to be phosphorylated by HPr is needed to
confirm that HPr is active in the assay.
ptsHI mutant strains were constructed in B. anthracis to identify if EI and HPr have an
indirect role in AtxA protein function. Deleting EI and HPr in B. subtilis has pleiotropic effects
on carbohydrate utilization and CCR (73, 164, 165). Loss of EI and HPr leads to a defect in
PTS-dependent sugar import due to the lack of phosphorylation of the EII complexes which
transport and phosphorylate a carbohydrate as it transits the cell membrane. Additionally,
disruption of ptsH will prevent CcpA/P-Ser-HPr from interacting with its target promoters. B.
subtilis ΔptsHI strains have reduced growth rates on several PTS sugars. In the conditions
used for my experiments, only a slight delay in replication was detected for the B. anthracis
ΔptsHI strain. However, removal of ptsHI resulted in a decreased amount of toxin gene and
atxA expression and AtxA protein. Loss of atxA transcript presumably led to the decrease in
the Plef-lacZ transcriptional reporter.
HPr and EI may affect atxA transcription via CcpA. Chiang et al. (66) determined that
CcpA indirectly increases atxA transcript level. It is also well-established in B. subtilis that
CcpA requires P-Ser-HPr in order to bind to target promoters (75). Due to the absence of
HPr in the ptsHI mutant, CcpA would not be able to bind to target promoters and this would
lead to misregulation of the atxA promoter.

93

Plasmids harboring IPTG-inducible ptsH, ptsI, and ptsHI were used to complement
the ptsHI mutation. Only the vector encoding HPr and EI was capable of increasing AtxA
protein in the mutant background. Over-expression of ptsH was not able to complement the
ΔptsHI mutation. These data indicate that both EI and HPr are needed for atxA expression.
Typically when both EI and HPr are needed for a function, it is due to EI-dependent
phosphorylation of HPr H15. However, I propose that HPr is interacting with CcpA and the
requirement of EI is related to the physiological state of the bacterium.
I reason that EI is needed for atxA expression, because EI increases fructose-1,6bisphosphate (FBP) levels leading to phosphorylation of HPr S46 by HprK/P. FBP is an
intermediate in glycolysis produced only when the PTS is functioning properly (74). In the
ΔptsHI strain, glycolysis may not function properly, thus FBP concentrations may be
significantly affected. In B. subtilis FBP concentrations can range between 1.8 mM to 14.1
mM depending on the carbon source and a ΔptsI strain has 1.8 mM FBP (149). HprK/P
phosphorylates HPr in an ATP-dependent manner when there is greater than 5 mM FBP in
the cell (166, 167).

Low levels of FBP would lead to less HprK/P activity and a lower

concentration of P-Ser-HPr.

Considering this information, I predict that loss of CcpA-

dependent CCA in the ΔptsHI strain was due to the lack of HprK/P phosphorylation of HPr
when Phs-ptsH was induced.

If CcpA/P-Ser-HPr regulates atxA, expressing a

phosphomimetic version of P-Ser-HPr (HPr S46D, (168)) in the ptsHI mutant could bypass
the requirement of EI and FBP.
Typically, PRD-harboring proteins are activated by HPr-dependent phosphorylation,
and their function is decreased upon phosphorylation via EIIA and/or EIIB. However, in B.
subtilis ΔptsHI strains, PRD-containing proteins either have no activity (82, 141, 153, 169,
170) or they are constitutively active (171, 172). The PRD proteins LicR, LicT, MtlR, and
ManR require phosphorylation by P~His-HPr to be active; therefore in the ptsHI mutant their
activity is depressed severely. In contrast, LevR and GlcT display constitutive activity in

94

ptsHI-null strains, because EIIA/B motifs are not able to phosphorylate the proteins to
repress the activity of the regulator (82, 159). Given these two scenarios, if AtxA function is
regulated by the PTS, an effect on AtxA activity should be detected in a B. anthracis ΔptsHI
mutant.
Deletion of ptsHI does not affect AtxA protein function when AtxA is induced from an
IPTG-inducible promoter. The activity of AtxA after induction in the ΔatxA and ΔptsHI strains
was compared to the parent strain which contains atxA controlled by its native promoter. In
toxin-inducing conditions (CACO3), all three strains contained AtxA and produced similar
levels of AtxA activity. In LB-air, which is not conducive for toxin gene expression, AtxA was
only detected when induced from Phs-atxA in the ΔatxA and ΔptsHI strains. The activity of
AtxA in each strain was similar, albeit 100-fold lower than the same strains in CACO3. If
regulated by the PTS, AtxA activity should be repressed or constitutive. These data indicate
that AtxA function is not regulated by ptsHI.
Taken collectively, the data support only one function of the PTS in virulence gene
regulation of B. anthracis. The phenotype of the ptsHI-null strain indicates that CcpA and
HPr activate transcription of atxA. Due to the lack of a phosphorylated product in vitro or an
effect on AtxA in the ΔptsHI, I conclude that EI and HPr do not play a role in activation or
repression of AtxA activity.
It is quite surprising that AtxA was not phosphorylated in the phosphotransferase
assay and that AtxA protein activity was not affected in the ΔptsHI mutant. To date, all PRDcontaining proteins tested are phosphorylated via HPr and thus regulated by the PTS. AtxA,
which has homology to PRD-containing proteins, would be unique in this sense. However,
AtxA contains structural features not found on PRD-containing antiterminators and is missing
a motif present in PRD-containing activators. PRD-containing antiterminators, such as LicT
and GlcT, contain an RNA-binding domain and two PRDs (73). DNA-binding proteins with
PRDs, including MtlR and LicR, have a DNA binding region, two PRDs, an EIIB-like motif,
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and an EIIA-like motif (73, 82). The motif structure of AtxA is predicted to be similar to MtlR
and LicR; however, the EIIA-like motif is absent.
Before my work, the phosphorylation state of only one protein within the AtxA/Mga
protein family has been investigated.

Using a phosphotransfer assay, the group A

Streptococcus virulence gene regulator Mga is phosphorylated via EI and HPr (McIver,
personal communication). Results obtained using phosphomimetic mutations indicate that
phosphorylation of H204 and H270 decreases Mga activity, whereas phosphorylation of
H324 increases the function of the protein.
Due to the lack of evidence that AtxA is phosphorylated by the PTS, it must be
considered that AtxA is not phosphorylated in vivo. The model proposed by Tsvetanova et
al. (59) suggests that AtxA is phosphorylated at H199 and H379. The data which support
AtxA phosphorylation include
antibody

and

the
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activities

P-labeled products that are immunoprecipitated by α-AtxA
of

dephosphorylation of AtxA (59).
immunoprecipitate

32

point

mutations

that

mimic

phosphorylation

or

After several attempts, I have been unable to

P-labeled AtxA from cells cultured with

32

P-phosphate. I have repeated

the experiments with the AtxA point mutants and included multimerization assays to gain
insight into the structural changes conferred by the point mutations.
Phosphomimetic mutations should simulate the ionic charge and size of the
phosphorylated amino acid. NMR studies comparing P-Ser-HPr and HPr S46D show that
the proteins have virtually identical structures (173). HPr H15D and HPr H15E have similar
affinities as P~His-HPr for HprK/P (174). Exchanging a phosphohistidine for an aspartic acid
is the standard mutation used in research of PRD-containing proteins (85, 135, 159). Both
aspartic acid residues and phosphohistidines are negatively charged, whereas the histidine
side chain is positive when the pH is below 6.0. The carboxyl group in the aspartic acid side
change also mimics the P-O bond in the phosphate moiety. These studies suggest that an
aspartic acid is an appropriate mimic of a phosphorylated amino acid.
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Using an aspartic acid residue to mimic phosphorylation of AtxA H379, I determined
that the mutation causes a change in the multimeric properties and activity of AtxA. AtxA
H199A, AtxA H199D, and AtxA H379A formed oligomers similar to the native protein. AtxA
H379D did not interact with AtxA-His during a co-AP experiment, and it was not susceptible
to BMH cross-linking.

If it is assumed that AtxA H199D and AtxA H379D represent

phosphorylated histidines, then these data are in agreement with the model for LicT
dimerization. LicT forms a dimer when sites of positive regulation are phosphorylated. The
dimer form of LicT is destabilized when phosphorylated at histidines that lower protein
activity (78–80).
Although the AtxA H379D mutation supports the model of PRD-containing proteins,
future experiments should be conducted to determine if the size or charge of the amino acid
R group is causing the multimerization defect. Asparagine, glutamic acid, glutamine, serine
and lysine could be tested instead of aspartic acid. Glutamic acid has a negative similar to
aspartic acid and serine contains a polar side chain. Asparagine and glutamine residues
contain similar shaped side chains as aspartic acid, except without the charge. Lastly, a
lysine would retain the positive charge but increase the size of the histidine side chain. If
AtxA H379E and AtxA H379S are the only point mutants to display phenotypes similar to
AtxA H379D, then the results would suggest that the mutations are mimicking a
phosphohistidine at position 379.

The data would also support the model that AtxA is

phosphorylated.
In summary, AtxA protein function is not regulated via the PTS; however the
transcription rate of atxA is affected, presumably via CcpA/P-Ser-HPr. Point mutations at the
predicted phosphorylation sites lead to the expected phenotypes when considering the
model of PRD-protein function. Future experiments will investigate if AtxA is phosphorylated
independent of the PTS.
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Chapter VI: Discussion
Discussion
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6.1 Significant findings regarding the structure and function of AtxA
AtxA is a critical virulence gene regulator of B. anthracis. A B. anthracis atxA–null
mutant is highly attenuated in murine models for anthrax (49, 106). The level and activity of
AtxA dictate levels of virulence gene transcription within cells. Steady state levels of AtxA
protein are impacted by transcriptional regulation of the atxA gene and protein stability.
Regulation of AtxA activity takes place via post-translational modification and structural
changes. Many details are known regarding regulation of the atxA promoter and the effect of
an atxA-null strain on virulence gene expression (46–48).

However, before the results

conveyed in this dissertation, researchers knew little about the molecular mechanism of AtxA
function.
My research has advanced the study of AtxA significantly. Chapter 3 describes my
work to characterize the activity of AtxA when induced by a heterologous promoter, to
analyze the two large domains within the AtxA protein, and to determine the affinity of AtxA
for DNA.

In Chapter 4, I describe experiments demonstrating that AtxA forms a

homomultimeric structure, possibly a dimer. Formation of the multimer is dependent upon
the EIIB-like motif, enhanced by CO2/bicarbonate, and may be needed for optimal AtxA
function. Data presented in Chapter 5 support previous evidence suggesting that CcpA/PSer-HPr regulates atxA transcription. On the other hand, my data challenged a previously
proposed model in which the PTS phosphorylates AtxA. I show that AtxA function is not
affected by EI or HPr. Finally, my studies on AtxA demonstrate that AtxA H379D is deficient
in multimerization while other H199 and H379 point mutations are able to form oligomers.
Overall, my data support the following model of AtxA function. Oligomers of AtxA
associate with specific promoter elements. AtxA activity is increased in response to the hostrelated signal CO2/bicarbonate because this signal enhances AtxA multimerization.

In

contrast, AtxA activity is decreased by phosphorylation at H379 because multimerization is
inhibited.

Figure 6-1 and the following section detail a comprehensive model of atxA-
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mediated virulence gene activation based upon previous data and new information
generated during my thesis work.

6.2 A comprehensive model of B. anthracis virulence gene regulation
Steady state levels of functional AtxA are affected by transcriptional regulation of the
atxA gene, post-translational covalent modification, and finally AtxA oligomerization. Transacting factors affect the activity of the atxA promoter via activation or repression of
transcription. Moreover, the stability of the message is impacted by elements encoded within
the atxA locus. One global regulator has been shown to affect AtxA protein level indirectly.
Finally, post-translational modification and ligand-binding may alter the functional state of the
protein.
Multiple proteins and signals affect atxA transcription (Fig. 6-1A). Positive regulators
include CcpA/P-Ser-HPr and physiological temperature (37° C) (64, 66). AbrB, genes
involved in cytochrome c biogenesis, and an unidentified repressor protein negatively impact
atxA transcription (65, 67, 68, 106). These regulators impact atxA transcription at the σAdependent P1 promoter and not at the secondary promoter (P2) (49, 63, 106). Additionally,
an extended 3’ end of the transcript is required for stability (175).
AtxA protein stability is controlled by the pleiotropic regulator CodY in an indirect
manner (Fig. 6-1B).

A ΔcodY strain of B. anthracis contains normal levels of atxA

transcription and translation; however the AtxA protein was not detected on Western blots of
whole cell lysates (62). The authors of the study suggest that either CodY represses an
unidentified protease that degrades AtxA or CodY activates an AtxA-binding protein and/or a
chaperone that promotes AtxA stability.
Once the atxA gene is transcribed and the protein is stable, AtxA must form the
proper structure via protein modification and ligand binding (Fig. 6-1C). The EIIB-like motif
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Figure 6-1. A comprehensive model of atxA-dependent virulence gene regulation.
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Figure 6-1. A comprehensive model of atxA-dependent virulence gene regulation. The
schematic represents three layers of control governing A. atxA transcription, B. AtxA stability,
and C. AtxA protein activity. Also presented are the major outcomes of D. AtxA function.
See text an explanation of the model. Straight arrows indicate direct regulation, whereas
dashed arrows suggest indirect or unknown routes of regulation. A. Upstream of the atxA
gene are sequences which are bound by repressors (red lines) or an activator (blue line) of
transcription. Transcriptional regulation occurs at the primary promoter (P1), not the
promoter located further upstream (P2). Downstream of the gene is an extended 3’
untranslated region and a stem-loop (Ω). B. The cartoon depicts five motifs within AtxA:
winged-helix-turn-helix (WH), Mga-like helix-turn-helix (HTH), two PTS regulation domains
(PRD1 and PRD2), and an Enzyme IIB-like motif (EIIB-like). C. A structural model of an
AtxA homodimer is shown (one subunit is red and the other is blue).
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facilitates formation of a homomultimeric structure and the amount of multimer correlates
with AtxA activity. These results suggest that the multimeric form of AtxA is needed for the
protein to be active. The mechanisms that induce or inhibit oligomerization are unknown;
however, phosphorylation of H379 may inhibit the multimer structure while CO 2/bicarbonate
may promote AtxA oligomer formation.
Once all three of these regulatory steps are overcome, B. anthracis virulence traits
are expressed (Fig. 6-1D). The anthrax toxin genes may be controlled directly by AtxA (46,
47), whereas AtxA activates PDGA capsule biosynthesis indirectly (Bourgogne 2003). AtxA
regulates several genes within the B. anthracis genome and indirectly inhibits sporulation
(57, 176).
For the remainder of my discussion, I will highlight several aspects of this model of
AtxA regulation.

6.3 atxA control by CcpA/P-Ser-HPr and CodY provides a link between metabolism and
B. anthracis virulence
Work presented in Chapter 5 provides support for roles of CcpA and HPr in the
regulation of the atxA gene. B. anthracis ΔccpA and ΔptsHI mutants contain a low steady
state level of atxA transcript compared to the parent strain (66). In a separate study, CodY
was shown to mediate AtxA protein stability (62).

B. anthracis mutants devoid of codY

exhibit a decrease in AtxA protein level. CcpA/P-Ser-HPr and CodY act indirectly on atxA to
regulate virulence presumably through different mechanisms. Intriguingly, both CcpA/P-SerHPr and CodY activity are influenced by the metabolic state of the bacterium. Therefore, I
postulate that the mammalian host provides metabolic signals that prompt B. anthracis to
induce transcription of atxA and stabilize the AtxA protein.
When the local concentration of glucose and other quickly metabolized
carbohydrates is high, CcpA/P-Ser-HPr represses and activates genes. Studies in B. subtilis
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have shown that phosphorylation of HPr S46 is required for the protein to form a heterodimer
with CcpA (73). HprK/P is responsible for phosphorylating HPr S46 in an ATP-dependent
manner when fructose-1,6-bisphosphate (FBP) concentrations are high. ATP and FBP are
abundant in cells growing on carbohydrates the bacteria can import and metabolize quickly,
such as glucose.
In B. subtilis, metabolism of glucose increases the cellular concentration of GTP,
which is an activating ligand of the regulator CodY.

Branched-chain amino acids (BCAA;

leucine, valine, and isoleucine) also increase activity of CodY. GTP levels are an indicator of
the energetic state of the cell while BCAA represent the abundance of nutrients (proteins) in
the environment. Either small molecule is able to induce DNA-binding; however there is an
additive effect when both interact with CodY (61).
Glucose and BCAA are readily available in the cytoplasm of host cells (177). Glucose
is the preferred carbon source for most host cells, and the normal concentration in plasma is
1 mg ml-1 (178). BCAA are available in tissue as proteins are broken down due to starvation
(179) or proteolytic enzymes, including InhA1 and NprB which are secreted by B. anthracis
(72, 105).
Signals and conditions associated with replication of B. anthracis in mammalian
tissue are simulated by toxin-inducing culture medium.

When cultured in CACO3 broth

incubated at 37° C with 5% atmospheric CO2, B. anthracis produces high levels of anthrax
toxin compared to other culture media and atmospheric conditions (Fig. 4-8 and 5-3, (47)).
CACO3 is a semi-defined medium that contains acid hydrolyzed casein (casamino acids) and
glucose among other nutrients (99). Casamino acids contain a mixture of all amino acids,
including the BCAA. Since glucose and BCAA promote the activity of CcpA/P-Ser-HPr and
CodY, respectively, I propose that the major signals influencing the amount of AtxA protein in
CACO3 are glucose and BCAA.
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CcpA/P-Ser-HPr and CodY are involved in the production and stability of AtxA. Since
these factors are active in the presence of glucose and BCAAs found in the mammalian host,
these data show a link between virulence gene activation and the metabolic state of the cell.

6.4 Regulation of AtxA protein function via multimerization
Host-related

signals

are

needed

also

to

promote

AtxA

protein

function.

CO2/bicarbonate and phosphorylation may regulate AtxA activity separately. It would be
interesting to study the interplay between CO2/bicarbonate and phosphorylation with respect
to AtxA activity and multimerization.

I propose that CO2/bicarbonate locks AtxA into an

active, multimeric state by facilitating rearrangement of the WH and HTH motifs. Without
CO2/bicarbonate, AtxA may still multimerize, but the DNA-binding activity could be reduced.
Phosphorylation of H199 may initiate formation of the oligomer via ionic interactions between
the phosphohistidine and a basic amino acid. On the other hand, phosphorylation at H379
may deactivate the protein by prohibiting multimerization.

This model for AtxA

multimerization is similar to the Domain Swing/Lock Mechanism of LicT (79). In this model,
AtxA transitions between three functional states: a monomer, an unstable multimer, and a
stable, highly active multimer.
The first prediction of the AtxA multimerization model proposes that AtxA has a
monomeric form and that the AtxA monomer does not activate target promoters.
Experimental evidence suggests that phosphorylation of H379 prevents proper multimer
formation. AtxA H379D did not interact with AtxA-His in a co-AP experiment and it was not
susceptible to BMH cross-linking (Fig. 5-4). These data suggest that phosphorylation of
H379 converts AtxA into a monomer; however, an alternative explanation is that H379
phosphorylation promotes formation of an unstructured aggregate.
The AtxA multimerization model suggests that an unstable oligomeric state for AtxA
serves as a transition point between monomeric and highly stable multimeric states. This
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stage would occur in the absence of any post-translational modification or CO2/bicarbonate
binding to AtxA. To replicate the non-phosphorylated state of AtxA, I could express AtxA
H199A and AtxA H379A. Characterization of the multimeric properties of AtxA H199A and
AtxA H379A could provide support for a transient stage of multimerization. AtxA H199A and
AtxA H379A are capable of forming normal AtxA multimers (Fig. 5-4). This indicates that
multimer formation is not dependent on phosphorylation of H199 or H379.

Culturing B.

anthracis in CA medium in air and the absence of added CO2/bicarbonate would simulate the
ligand-free state of AtxA. In this growth condition, AtxA multimer formation and toxin gene
expression are reduced to 50% of the levels observed in the same conditions but with added
CO2/bicarbonate (Fig. 4-8). Since the AtxA multimer was able to form in normal atmospheric
conditions, AtxA may form a weak oligomer in the absence of CO2/bicarbonate or the small
molecules may affect AtxA indirectly.
The final form of AtxA suggested by the AtxA multimerization model is a stable, highly
active dimer. Ligand-binding and phosphorylation of H199 are the likely modifications needed
to lock the AtxA multimer into its active conformation. The relatively low level of toxin gene
transcription in strains containing AtxA H199A supports the requirement of H199
phosphorylation for oligomerization. Although the H199A protein displays normal multimers,
it produces less than 33% of the activity of native AtxA (Fig. 5-4).

Disruption of

phosphorylation at H199 may weaken the AtxA multimer resulting in loss of AtxA activity.
I proposed in section 4.3 that CO2/bicarbonate may bind to AtxA.

At the 2011

International Conference on Gram-Positive Microorganisms, data were presented suggesting
that N453 of AtxA was involved in binding bicarbonate and had an impact on AtxA solubility
(Fouet, personal communication).

The carboxy terminus of AtxA (amino acids 438-469)

bears weak similarity to the first 32 amino acids of RegA, and within that region, AtxA N453
aligns with RegA N16 suggesting the residues perform similar functions.

RegA, an

AraC/XylS-type bicarbonate-binding transcription factor of Citrobacter rodentium, interacts
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with bicarbonate via an amino-terminal motif (144, 145). Mutation of RegA N16 to an alanine
results in constitutive activation of RegA-dependent promoters presumably by mimicking the
structural changes induced by bicarbonate. The model of RegA activity proposes that two
proteins form a dimer via their amino-termini when bicarbonate is present. Activity of AtxA
N453A in normal air was similar to AtxA cultured in elevated CO2/bicarbonate.

If AtxA

functions similarly to RegA with respect to bicarbonate binding and multimerization, then
bicarbonate-binding would lock AtxA proteins together in a multimeric structure. Without
bicarbonate, AtxA oligomers could form, but they would not be stable.
Applying the Domain Swing/Lock Mechanism to AtxA, I propose that phosphorylation
and bicarbonate affect AtxA function by altering its multimeric structure. Monomers of AtxA
are prohibited from forming oligomers when H379 is phosphorylated. When bicarbonate
concentrations are low and the protein is not phosphorylated, AtxA is in a transitional form
capable of forming weak protein-protein interactions. The AtxA multimer is locked in a highly
active state when H199 is phosphorylated and bicarbonate interacts with N453.
Several experiments may be performed to test the model of AtxA homodimer
formation. If the energy transfer between two different AtxA-chromophore fusions can be
detected in vivo, Förster resonance energy transfer (FRET) experiments could detect
formation of AtxA multimers. To observe CO2/bicarbonate enhancement of multimerization,
FRET measurements may be collected using cells cultured in the presence or absence of
elevated atmospheric CO2 and dissolved bicarbonate. I would expect to see greater energy
transfer when CO2 and bicarbonate are present.

Additional FRET experiments utilizing

various culture media (LB and CA) or point mutations within one or both AtxA fusions may
provide additional support for the role of AtxA phosphorylation on the stability of AtxA
oligomers. Point mutants of AtxA could also be tested in vitro by performing size exclusion
chromatography, analytical ultracentrifugation, or surface plasmon resonance.
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Extensive analysis of an AtxA-bicarbonate interaction has not been done. It may be
possible to detect

14

C-labeled bicarbonate bound to AtxA. One method would be to affinity-

purify AtxA-His expressed in cells cultured in the presence of

14

C-bicarbonate. If samples

containing AtxA had a higher radioactive signal than control samples (no 14C-bicarbonate and
samples without AtxA), the results would indicate that bicarbonate is a ligand of AtxA. A
similar experiment can be performed in vitro using purified AtxA-His.

Adding unlabeled

bicarbonate to purified AtxA-His when performing in vitro multimerization assays or DNA
binding experiments could enhance the activity of AtxA. If AtxA binds bicarbonate and the
binding is lost when AtxA N453A is tested, then N453 of AtxA may function similar to RegA
N16 and interact with bicarbonate.

6.5 Specific DNA binding by AtxA
The proposed Domain Swing/Lock Mechanism of AtxA multimerization describes the
various quaternary structures that may exist for AtxA. Each structure either promotes or
prohibits AtxA function in vivo. As suggested above, the role of AtxA is to bind to target
promoters to enhance transcription of the genes. Work presented in Chapter 3 demonstrates
that AtxA can bind to DNA promoters; however, AtxA interacted with the sequences nonspecifically. This portion of the discussion will address the reasons why AtxA bound nonspecifically to DNA and propose future methodologies to attempt when studying AtxA-DNA
interactions.
Filter binding assays were used to assess the interaction between AtxA and promoter
sequences.

The experiment detects DNA when it has complexed with a protein and

subsequently binds to a membrane. In effect, the protein precipitates onto the membrane,
and DNA is captured during the precipitation. The protein-DNA affinity is determined using
target promoters, whereas other DNA sequences are used to control for non-specific proteinDNA interaction.
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The filter binding assay has been used to study many proteins and is a valid
technique; however, it may not be the best method to study AtxA-DNA interactions.
Precipitation of AtxA, a highly positively charged protein, onto the membrane could indicate
falsely that the protein is binding to DNA sequences in the assay. In addition, the interaction
of the DNA and protein does not need to be very strong. The method does not require any
wash steps and there is little opportunity for DNA and protein to dissociate if they are nonspecifically interacting.
During in vitro analyses, AtxA may be able to bind DNA independent of its multimeric
state. Recently, Hondorp et al. described how Mga forms a multimer in solution and that an
EIIB-like motif is needed for the protein-protein interaction (180). Interestingly, the authors
tested the DNA-binding activity of a derivative of Mga lacking the EIIB-like motif. Although
the truncated protein was a monomer in solution and had no detectable activity in vivo, it
bound to DNA with only a slightly weaker affinity (less than 2-fold change) compared to the
full-length protein. These data suggest that Mga, and by extension AtxA, may bind to DNA in
these in vitro assays as a monomer, whereas a dimeric protein is needed in the cell to bind
DNA and activate transcription.
There is some precedence for in vitro DNA binding occurring in the absence of the
appropriate multimeric state. For example, PhoP, a response regulator involved in Mg 2+
homeostasis in Salmonella typhimurium, typically binds DNA as a dimer after it is
phosphorylated (181). However, when present in high concentrations, unphosphorylated
PhoP binds DNA as a monomer and then recruits the second monomer to the binding site.
The affinity of the first monomer to DNA is ~17-fold higher than the affinity of the second
monomer to the binding site. These studies were conducted using biophysical methods
including isothermal titration calorimetry, fluorescence titration measurements, analytical
ultracentrifugation, and surface plasmon resonance. It would be interesting to see if similar
results would be seen using a filter binding assay. I suggest that the binding affinity of the
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second monomer of PhoP would be masked by the affinity of the first protein. Once one
protein binds to the DNA probe, the probe will stay on the membrane regardless if the
second monomer is present or not. If AtxA follows a similar mode of DNA binding where one
subunit interacts with DNA with a higher affinity than the second subunit, then I would be
detecting only the interaction of the first subunit.
For dimeric DNA binding proteins, interaction of the second monomer provides
specificity and optimal affinity of the protein to its cognate DNA (182). In several eukaryotic
systems, DNA-binding proteins within the same family have similar recognition sites. The
transcription factors achieve specificity by recognizing a predetermined length between the
binding sites. In vitro several proteins can bind to half sites as a monomer, and full binding
by a dimer only occurs when the spacer between the sites is the correct size. AtxA may be
similar in this regard. AtxA may bind to a pair or series of specific nucleotide sequences or
structural elements. If only one of the sites is present on the non-specific probe used in the
filter binding assay, then AtxA will be able to form a complex and an interaction will be
detected.
In addition to the methods mentioned above in the study of PhoP, Electrophoretic
mobility shift assays (EMSAs), fluorescence polarization, and DNA foot-printing analyses
may provide additional information regarding the mechanism and affinity of AtxA to DNA.
EMSAs allow the protein-DNA complex to be visualized and if more than one form of the
complex is present, they will be detected. EMSAs may be problematic due to the high pI of
AtxA (pI = 9.3). At a neutral pH, AtxA is highly positively charged and migrates toward the
cathode rather than the anode like the DNA. However, the poly-acrylamide concentration of
the gel and pH of the buffer may be optimized to permit analysis of AtxA via this technique.
Fluorescence polarization assays allow for protein-DNA interactions to be viewed in real-time
as they occur in solution. The assay would not distinguish between a monomer of AtxA and
a multimer of AtxA; however, it would remove the precipitation step needed for a filter binding
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assay.

Lastly, foot-printing experiments could provide sequence-specific information

regarding the AtxA-DNA interaction. The size of the region protected in the experiment could
indicate the number of AtxA molecules interacting with the DNA element.
The experimental methodology may not be the cause of the non-specific binding of
AtxA. It is possible that AtxA is not in the proper form. The dimer form of AtxA may not be
the dominant species of the protein in solution. Post-translational modification and ligandbinding may confer structural changes within the protein that allow it to specifically interact
with DNA. Point mutations of AtxA could mimic the structural changes needed for DNAbinding.

6.6 A structural model of AtxA
Early attempts to crystallize AtxA or determine the solution structure via NMR
spectroscopy were not successful. Nevertheless, obtaining the structure of AtxA remains a
worthwhile pursuit. Until a crystal or NMR structure is determined, modeling AtxA against
known structures can be informative and guide future experiments. Fortunately, the structure
of an AtxA/Mga family member has been solved.
The 2.31 Å-resolution crystal structure of the Mga-like protein from Enterococcus
faecalis was determined recently (PDB file = 3SQN, (88)). The protein is encoded by the
gene EF_3013 and annotated as a “conserved domain protein.” No functional information
about this protein or gene is known. The structural motifs of the Mga-like protein match
those predicted to be in the AtxA/Mga family. Two HTH, two PRDs, and an EIIB-like motif
are present producing a structure that is 56% alpha helical and 9% beta sheet. The protein
crystallized as a dimer in which the EIIB-like motif of one subunit interacts with the PRDs and
HTH motifs of the other subunit (Fig. 1-4). In total, 83 residues are involved in the dimer
interface with an area of 3182.8 Å2 according to the “Protein interfaces, surfaces, and
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assemblies” software (PISA, (183)). It is not known if the structure represents an active state
of the protein or if the protein forms a homodimer in vivo.
I used the protein homology/analogy recognition engine (Phyre2, (137)) and the
Swiss-pdb viewer (184) to construct a structural model of an AtxA homodimer using the Mgalike protein as a template (Fig. 6-2 and 6-3A). The Mga-like protein has 19% identity and
39% similarity (total conservation = 58%) to AtxA. The model contains residues 89-474 of
AtxA which encompass the Mga-HTH, PRDs, and the EIIB-like motif. The WH motif is not
present in the structure generated by Phyre2. I have used the structural model to make
predictions about the functions of AtxA motifs as well as locations of specific residues.
Viewing the overall motif organization, I can make two observations. First, the EIIBlike motif is at the center of the homodimer (Fig. 6-2). As is true for the structure of the Mgalike protein, the EIIB-like motif from one chain reaches into a pocket created by the PRDs
and EIIB-like motif of the second subunit. If the protein lacked the EIIB-like motif, all contact
between the subunits would be lost. In addition, the EIIB-like motifs from each monomer
form few contacts with each other; therefore, EIIB-like motifs may not interact if expressed
independently. My data suggesting that the EIIB-like motif is necessary, but not sufficient, for
dimerization fit this model. The second observation is that HTH motifs from both chains are
on the same face of the dimer, and the motifs are extended from the remainder of the
protein. Typically, the HTH motifs of dimeric DNA-binding proteins are located on the same
side of the complex (126). In addition, the first residues of the recognition helix of each
subunit are separated by approximately 98 Å.

Since one turn of DNA is 34 Å and

encompasses ten nucleotides, the distance between the HTH motifs suggests that AtxA
binding sites may be separated by greater than 30 bp. The location of the motifs would allow
AtxA to bind DNA.
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Figure 6-2. A structural model of the AtxA homodimer. A stereo image of a structural
model of AtxA was created using Phrye2 based on the the X-ray crystal structure of the Mgalike protein from E. faecalis (PDB = 3SQN, chain B). The motifs of one subunit are colored:
HTH is red, PRD1 is yellow, PRD2 is cyan, and EIIB-like motif is blue. The WH motif was not
modeled. The second subunit is grey.
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After viewing the locations of several key residues, I can provide additional analysis
of their roles in AtxA function and their use in my experiments. In section 4.2.3, I described
experiments using CS mutations of AtxA to determine the cysteine required for BMH to
cross-link two AtxA proteins. After fixing cell lysates with BMH, AtxA C402S was present
only as a monomer, whereas the other CS mutations, including AtxA C161S and AtxA
C202S, were dimers. When native AtxA and AtxA C402S-FLAG were co-expressed in B.
anthracis, AtxA C402S-FLAG remained as a monomer indicating that it was not able to
cross-link with AtxA. These data suggested that C402 cross-linked to the corresponding
C402 of the second subunit (C402’). The data clearly indicate that C402 participates in the
BMH cross-linking; however, the binding partner of C402 could not be C402’ if the structural
model is accurate. C402 is located on the opposite side of the dimer interface from C402’
(Fig. 6-3B). Using the Swiss-pdb viewer software, the residues are over 46 Å from one
another, which is much greater than the size of the spacer arm of BMH (13 Å). When
locating the other cysteines in the AtxA model, I detected a region that contained C161,
C202, and C402’ within 12 Å of each other (Fig. 6-3C). Theoretically, C402’ could cross-link
to C161 or C202 with equal affinity. However, intermolecular cross-linking of C402’ to C161
or C202 may compete with intramolecular BMH bonds between C161 and C202. BMHmediated cross-linking of C161-C202 of AtxA C402S-FLAG may explain why the mutant
protein was not fixed to native AtxA (Fig. 4-5C). To address if C402’ cross-links to C161 or
C202, I could determine if AtxA C161S/C202S is susceptible to BMH cross-linking.
In addition to C402 being important for the BMH cross-linking experiment, it may have
a significant role in vivo. As described in section 4.3, C402 resides within the P-loop of the
EIIB-like motif which is a conserved region that contains a phosphorylated cysteine in EIIB
motifs of the PTS (138). In the AtxA structural model, C402, and thus the P-loop, may
contact residues in the adjoining AtxA molecule and phosphorylation of this loop may
significantly impact multimerization. Moreover, the pocket containing C402’, C161, and C202
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Figure 6-3. Areas of interest in the structural model of the AtxA homodimer.
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Figure 6-3. Areas of interest in the structural model of the AtxA homodimer. Three
areas of the AtxA homodimer contain residues that have been shown to be important
experimentally or in silico. A. The model of the homodimer is presented alongside a 90°
rotation of the structure. One monomer is colored blue and the other is grey. Side chains of
the important residues are depicted as spheres. The color scheme is the same for all
panels. B. The EIIB-like motifs from both chains are displayed. The C402 residues (yellow)
are on opposite sides of the motifs. Between the motifs, R415, F468, and K472 (red) may
form a metal-binding pocket. C. The region surrounding C402 (yellow) from one monomer
contains C161, H199, C202, and H379 (magenta) from the second subunit. D. Depicted is
a potential interaction between N453 (orange) of the AtxA EIIB-like motif and the WH motif
(green) from the structure of the Mga-like protein (PDB = 3SQN, chain A).
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also harbors H199 and H379, the phosphorylation sites of AtxA (Fig. 6-3C). If C402 is
phosphorylated, it may present an ionic clash and steric hindrance with a phosphohistidine at
H199 or H379.
The AtxA structural model displays residues that may interact with phosphorylated
H199 and H379.

According to the Domain Swing/Lock Mechanism, phosphohistidine at

H199 should increase the stability of an AtxA dimer. The phosphohistidines of LicT interact
with arginine residues of the adjacent subunit (135). H199 slightly extends into the adjacent
EIIB-like motif suggesting that it forms important contacts.

AtxA H199-phosphate may

interact with R424’ to increase the AtxA-AtxA affinity. Likewise, H379 extends away from the
core of PRD2 and toward the interface with the EIIB-like motif of the second AtxA subunit.
The helix containing H379 also harbors several non-polar residues (L375, M378, T382, and
M385) that face non-polar amino acids on the complementary alpha-helix of the EIIB-like
motif (I403’, Y406’, and L411’). H379 in its non-phosphorylated form may interact with Y406’.
When phosphorylated, H379 could disrupt the hydrophobicity of the region and destabilize
the dimer.

The AtxA multimerization model predicts that H379 inhibits proper multimer

formation.
In silico analysis of the AtxA structural model suggests that zinc and magnesium may
bind to the protein. The 3DLigandSite Server (185) suggests that R415, F468, and K472 of
both AtxA subunits interact with the metal ions. It is significant that these residues form an
interface between the EIIB-like motifs of each subunit (Fig. 6-3B). A metal ion may also bind
the Mga protein of GAS. McIver and co-authors have suggested that Mga chelates a metal
as it is expressed in E. coli and S. pyogenes (McIver, personal communication). Mutation of
R415, F468, and K472 may have a substantial impact on homodimer formation and metal
binding.
Another interesting observation was made when constructing a model of a
heterodimer of the Mga-like protein and AtxA. In the model, N453 of AtxA resides next to a
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loop between the WH and HTH motifs of the Mga-like protein (Fig. 6-3D). The structure of
the loop (Mga-like protein residues 76-78) was not detected in the Mga-like protein crystal
structure which suggests that it is flexible.

As described above, Fouet and colleagues

suggest that N453 binds to bicarbonate (Fouet, personal communication). If N453 interacts
with a bicarbonate ion, then the loop may become more rigid and alter the conformation of
the adjacent WH and HTH motifs. The change in WH and HTH orientation may allow AtxA to
bind DNA efficiently and specifically. Bicarbonate binding via N453 may be the final step in
AtxA dimerization.
The structural model of the AtxA homodimer has provided support for my
experimental data. As with all in silico analyses, this structural model provides rationale for
many additional experiments.

6.7 Concluding remarks
Future studies of AtxA will answer several lingering questions. Does AtxA bind to
bicarbonate? Which proteins phosphorylate AtxA? Does AtxA form a dimer and is that
dimer structurally similar to the Mga-like protein? How does AtxA associate with DNA?
Future data will support an emerging model in microbial pathogenesis which suggests
that there is a relationship between host signals and virulence gene expression.

Many

pathogenic bacteria effectively colonize environmental niches that are very different from the
conditions within their susceptible host. Borrelia burgdorferi inhabits a tick before infecting a
mammal, Vibrio cholerae is a water-borne bacterium prior to taking up residence in the
human intestines, and B. anthracis dwells in the soil before rapidly replicating within its host.
Signal transduction pathways leading to virulence gene expression must differentiate
between the cues in each location.
physiology.

Interestingly, these signals affect basic bacterial

B. anthracis senses the temperature, carbohydrate availability, and

CO2/bicarbonate concentration to regulate atxA and virulence gene expression. My doctoral
118

studies have helped to understand the link between these fundamental processes and
pathogenesis.
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